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ABSTRACT 
Dietary Interventions against Mammary Gland and Prostate Cancers 
By Juliana Adedayo Akinsete 
Dietary components modulate normal cellular functions and, in cancer cells, alter processes that 
lead to cancer and/or its progression. The change in the patterns of human food production and 
consumption over time has contributed to increasing risk for diseases including cancer. Omega-3 
and omega-6 fatty acids are classes of essential polyunsaturated fatty acids in the human diet and 
are required for normal growth and development. Omega-3 and omega-6 fats are thought to be 
required in the ratio of 1:1 to 1:4 on which humans are thought to have evolved however, the 
Western diet has greatly shifted from this ratio. The Western diet consists of high omega-6 and 
low omega-3 fat ratio as high as 50:1. Consumption of a diet high in omega-3 fat is associated 
with reduced risk for some cancers, whereas consumption of a diet high in omega-6 fat is 
associated with increased risk. We hypothesized that canola oil in the maternal diet or, regular 
walnut consumption, or fish oil in adult diet as sources of omega-3 fat to increase omega-3 fat 
and reduce omega-6 fat in the diet, might reduce the risk for breast and prostate cancers in the 
C3(1)TAg mouse. Consumption of high omega-3 diet from canola oil by mothers suppressed 
mammary gland tumorigenesis in the female offspring. Walnut consumption suppressed 
mammary gland tumorigenesis more than high omega-3 diet from canola oil, and high omega-3 
diet from fish oil suppressed prostate tumorigenesis.  
 
 
iii 
 
 
Dedication 
First and foremost I thank God for His grace and strength I daily experienced throughout my 
study. I appreciate Him for giving me a wonderful and supportive family. To my husband, 
Alfred, I say thank you for being ever loving and caring. To my children, Ayokunle and 
Moyosore, thank you for your understanding and forbearance. I love you all. This work is 
dedicated to the glory of God and to my family.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
AKNOWLEDGEMENTS 
I would like to extend my sincere gratitude to my advisor and mentor Dr. Elaine Hardman for her 
support and encouragement all through my time in her lab. I would also like to thank Dr. Niles, 
Dr. Moore, Dr. Santanam and Dr. Delidow for their invaluable advice and support over the 
course of my doctoral program. I would like to extend my thanks to Dr. Gabriela Ion for her 
technical advice and Dr. Goran Boskovich for the gene array analysis. Thanks to Bianca Lycans, 
Ronald, Ted Witte, and several Undergrads who came in to the lab for taking care of the mice. I 
thank Johannes Farmahn for helping with histology evaluation and Margaret McFarland for 
taking her time to help with the scanning of my western blot films. To my fellow student, Anne 
Silvis, I say thanks for your help, support and kindness. Finally, I would like to thank Julia 
Schrieber, Connie Berk, Stephanie Van Meter, Andrea Belalcazar, Paula Kouns, Diana Maue, 
Marie Murphy, Anita Mathis and Tawnia Mathis for their friendliness and kindness. THANK 
YOU ALL! 
v 
 
TABLE OF CONTENTS 
TITLE PAGE …………………………………………………………………………………..….i  
ABSTRACT …………………………………………………………………………………….....ii  
DEDICATION PAGE ………………………………………………………………………..…..iii  
ACKNOWLEDGEMENTS .………………………………………………………………..…….iv  
TABLE OF CONTENTS ………………………………………………………………………….v  
LIST OF FIGURES ……………………………………………………………………………...vii 
LIST OF TABLES …………………………………………………………………………….…..ix  
LIST OF ABBREVIATIONS ……………………………………………………………………..x  
CHAPTER ONE: INTRODUCTION ………………………………………………………….…1  
Diet and the risk of cancer ………………………………………………………………….....1  
Omega-3 and omega-6 fatty acids……………………………………………………………..3  
Metabolism of omega-3 and omega-6 fatty acids and their effects on cancer …………......5  
Breast cancer …………………………………………………………………………………...9  
Morphology of the mammary gland ………………………………………………………....11  
Breast cancer classification ……………………………………………………………….…..12  
Prostate cancer ………………………………………………………………………….……..14  
Anatomy and histology of the human and mouse prostate …………………………………15  
Hormone responsiveness in prostate cancer ………………………………………………....17  
Pathological classification of prostate cancer ………………………………………….…….18  
Mouse model …………………………………………………………………………………...19 
STUDY OBJECTIVES …………………………………………………………………………....21  
CHAPTER TWO: Maternal consumption of canola oil suppressed mammary gland 
tumorigenesis  in C3(1) TAg mice offspring …………………………………………………......22 
       ABSTRACT ……………………………………………….………………………………......23 
      BACKGROUND ……………………………………………………………………………....24 
vi 
 
      METHODS …………………………………………………………………………………….28 
      RESULTS ……………………………………………………………………………………...34 
      DISCUSSION ………………………………………………………………………………….47 
      CONCLUSIONS ……………………………………………………………………………....50 
CHAPTER THREE: Dietary walnut suppressed mammary gland tumorigenesis in  
the C3(1) TAg mice ………………………………………………………………………….........53 
     ABSTRACT ……………………………………………………………………………………54 
     INTRODUCTION ……..………………………………………………………………………55 
     METHODS AND MATERIALS ………..…………………………………………………….57 
     RESULTS ……..………………………………………………………………………………..63 
     DISCUSSION …….…………………………………………………………………………….75 
     CONCLUSION ….……………………………………………………………………………..78 
CHAPTER FOUR: Consumption of high omega-3 fatty acid diet suppressed prostate 
tumorigenesis in C3(1) TAg mice …………………………………………………………………81 
     ABSTRACT ………………………………….………………………………………………....82 
     INTRODUCTION ……….……………………………………………………………………..83 
     MATERIALS AND METHODS ……………………………………………………………...85 
     RESULTS ….…………………………………………………………………………………...92 
     DISCUSSION …………………………………………………………………………………105 
     CONCLUSION ……………………………………………………………………………….105 
CHAPTER FIVE: GENERAL DISCUSSION AND FUTURE DIRECTIONS……………..111 
     DISCUSSION …………………………………………………………………………………111 
     FUTURE STUDIES …………………………………………………………………………..111 
     REFERENCES ………………………………………………………………………………..120 
 
 
vii 
 
LIST OF FIGURES 
Figure 1.1  Diet and cellular processes linked to cancer 
Figure 1.2  Structures of omega-3 and omega-6 fatty acids 
Figure 1.3  Synthesis of longer-chain omega-6 and omega-3 fatty acids 
Figure 1.4 Schematic view of mammary gland morphology 
Figure 1.5 Schematic view of the anatomy of the human and mouse prostate 
Figure 1.6 Schematic view of the cell types in the human and mouse prostatic duct 
Figure 1.7 Schematic illustration of prostate cancer progression 
Figure 2.1  Mean body weight gain between 21 and 130 days of age  
Figure 2.2  Tumor incidence and multiplicity at 130 days of age 
Figure 2.3  Tumor multiplicity at 170 days and growth rate 
Figure 2.4  Glands with tumor per mouse with time 
Figure 2.5  Results of protein analyses for fatty acid synthase (Fas) and 
CCAAT/enhancer binding protein (C/EBP), beta at 130 days of age 
Figure 3.1       Gas chromatography for fatty acids in mammary gland 
Figure 3.2  Tumor mass, multiplicity and incidence at 130 and 145 days of age 
Figure 3.3  Protein quantification for genes of interest in NFkB pathway 
Figure 3.4  Glands with tumor per mouse for corn oil/corn oil (CO/CO), 
 canola oil/canola oil (CA/CA) and walnut/walnut groups 
Figure 4.1 Effect of diets on average body weight gain, prostate weight  
and GU weight  between CO-CO and CO-FS mice 
 
viii 
 
Figure 4.2 Effect of diets on the incidence of PIN and adenocarcinoma  
lesions in the DL prostate 
Figure 4.3 Effect of diets on plasma testosterone and estradiol levels 
Figure 4.4 Effect of diets on proteins in NFkB and apoptosis pathways in DL prostate 
Figure 4.5 Effect of diets on the extent of proliferation and apoptosis in DL prostate 
Figure 4.6  Effect of diets on major ω-3 and ω-6 fatty acid levels in mice tissues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
LIST OF TABLES 
Table 2.1 Composition of the animal diets 
Table 2.2   Major omega 6 and omega 3 fatty acids in tissues of mice  
Table 2.3 Genes expression in mammary glands at 130 days of age  
Table 3.1  Compositions of the diets 
Table 3.2  Gene expression altered by walnut diet 
Table 4.1 Diet Composition 
Table 4.2  Gene expression in dorsolateral prostate at 24 wks of age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
LIST OF ABBREVIATIONS 
AA  Arachidonic acid 
ADC  Adenocarcinoma 
ALA     Alpha linolenic acid 
AP  Anterior prostate  
AR  Androgen receptor  
BHT  Butylated hydroxyl toluene 
C3(1)  Prostate steroid binding protein  T-antigen 
CA  Canola oil containing diet 
CEBPβ CCAAT/ enhancer binding protein β 
CO   Corn oil containing diet 
CO/CO Mother fed with corn oil containing diet, baby fed with corn oil containing 
diet after weaning 
CO/FS Mother fed with corn oil containing diet, baby fed with fish oil containing 
diet at puberty 
CO/walnut Mother fed with corn oil containing diet, baby fed with walnut containing 
diet after weaning 
DHA  Docosahexaenoic acid 
DL  Dorsolateral prostate 
DPA    Docosapentaenoic acid 
EPA   Eicosapentaenoic acid 
ERα  Estrogen receptor alpha 
Fas   Fatty acid synthase 
xi 
 
FS  Fish oil containing diet 
GAPDH  Glyceraldehyde 3 phosphate dehydrogenase 
GU  Genitourinary bloc 
H & E  Hematoxylin and eosin 
HGPIN High grade prostatic intraepithelial neoplasia 
Ikbkb (IKKβ) Inhibitor of κB kinase beta  
IPA  Ingenuity pathway analysis software 
LA    Linoleic acid 
LGPIN Low grade prostatic intraepithelial neoplasia 
Nfkbia (IKα) NFkB inhibitor  alpha 
NOS2  Nitric oxide synthase Type II 
PCNA  Proliferating cell nuclear antigen 
PIN  Prostatic intraepithelial neoplasia 
PUFA  Polyunsaturated fatty acid 
SV40 Tag  SV40 Large T-antigen 
VP  Ventral prostate 
Walnut/CO Mother fed with walnut containing diet, baby fed with corn oil containing 
diet after weaning 
ω-3(n-3)  Omega 3 fatty acid 
ω-6(n-6)   Omega 6 fatty acid
1 
 
CHAPTER ONE 
INTRODUCTION 
Diet and the risk of cancer 
There have been remarkable changes in the production and consumption of food due to 
industrialization and/or urbanization. Such changes have resulted in reduced risk of some dietary 
deficiencies, increased food production and improved overall nutrition. However, in many 
societies these changes have also resulted in adverse shifts in diet composition so as to include 
high fat content and higher consumption of omega-6 fatty acids (Simopoulos, 2008). For 
example, the Western world consumes more total fat, with high amounts of omega-6 and low 
amounts of omega-3 fatty acids in their diet relative to the rest of the world (Cordain et al., 
2002). These changes in diet composition are thought to influence the risk of obesity, 
cardiovascular disease, cancer, inflammatory and autoimmune diseases (Simopoulos, 2002).  
 Cancers in the human can be caused by genetic factors and the incidence may also be 
determined by external factors such as diet (Doll and Peto, 1981). Dietary components modify 
several processes in normal as well as in cancer cells (Milner, 2004). In normal cells, food and 
their nutrients are needed for normal functioning of all biological processes. In cancer cells, over 
500 dietary components have already been identified as possible modifiers of cancer processes 
(Milner, 2002). As the adage goes, we are what we eat. Dietary components can either inhibit 
processes that lead to cancer or contribute to its development. For example, feeding a diet that is 
high in fat, but low in calcium and vitamin D, increased colon cancer in rodents (Wargorich, et 
al., 1990 ; Newmark et al., 1990), and feeding with black raspberries inhibited esophageal 
tumorigenesis in mice (Kresty et al., 2001). 
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Fig. 1.1: Diet and cellular processes linked to cancer 
 
Diet can influence several fundamental processes (Fig. 1.1) involved in the promotion or 
inhibition of the development and progression of cancer. For example, retinoids can inhibit 
proliferation of cancer cells by inducing apoptosis or convert abnormal cells to normal cells by 
inducing differentiation (Sporn et al., 1984).  Phytoestrogens, which are abundant in soya beans, 
can inhibit the proliferation of cancer cells (Adlercreutz, 2002). Vitamin A induces cell cycle 
arrest (Bohnsack and Hirschi, 2004) and high insulin, which may increase body fat, can promote 
tumor growth (Yakar et al., 2005). Some studies also showed that feeding mice with a diet high 
in omega-3 fatty acid from canola oil or walnuts, compared to feeding mice with a diet 
containing corn oil diet, resulted in reduced growth rate of implanted human breast cancer 
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(Hardman, 2007; Hardman and Ion, 2008). Furthermore, fish oil supplements have been shown 
to decrease the number of tumors in an animal model of colorectal cancer (Rao et al., 2001).  
Long-chain omega-3 (eicosapentaenoic acid), abundant in fish oil (Petrik et al., 2008), can 
suppress tumor proliferation (Nkondjock et al., 2003) by inhibiting the signaling of activated 
oncogenes (Collett et al., 2001).  
The incidences and rates of cancer vary from one region of the world to another, with 
overall incidence rates being higher in the developed world than in the developing world, but the 
overall mortality rates are generally similar (Jemal et al., 2011). There is a rapid change observed 
in cancer rate after migration from one region to another. In general, migration results in dietary 
changes which are followed by changes in disease pattern within one or two generations. Studies 
have shown that people migrating between areas with different cancer incidence rates tend to 
acquire the cancer rates characteristic of their new location (McMichael et al., 1980), implying 
that lifestyle factors, such as diet, profoundly affect the risk for cancer and therefore cancer can 
be prevented.  
 
Omega-3 and omega-6 fatty acids 
Alpha linolenic acid (ALA) and linoleic acid (LA) were discovered as essential fatty acids some 
80 years ago (Burr and Burr, 1973). ALA and LA belong to the families of omega-3 (ω-3) and 
omega-6 (ω-6) fatty acids respectively. Fatty acids consist of a chain of hydrogen and carbon 
atoms with a methyl group at the tail (ω) end and a carboxyl group at the head (δ) end (Fig. 1. 2). 
The carbon atoms may be connected by single or double bonds. Saturated fatty acids contain 
the maximum level of hydrogen atoms possible and are therefore single bonds. Polyunsaturated 
fatty acids have bonds not saturated with hydrogen and therefore have two or more double bonds 
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connecting carbon atoms.  In omega-3 fatty acids, the first double bond occurs on the third 
carbon atom from the ω end, whereas in omega-6 fatty acids, the first double bond is on the sixth 
carbon atom from the ω end. 
 
 
 
Fig. 1.2. Structures of omega-3 and omega-6 fatty acids 
 
 
Omega-3 and omega-6 fatty acids are the two major classes of polyunsaturated fatty acids 
found in the human diet.  Both are essential dietary components for normal growth and 
development of human beings as they cannot be synthesized by humans. Omega-3 and omega-6 
fatty acids are known to have opposing physiological functions (Simopoulos, 2008). They are 
not interconvertible because mammalian cells lack the converting enzyme, omega-3 (delta-15) 
desaturase (Kang, 2004). ALA is a precursor for the synthesis of other members of the ω-3 
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family, namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). ALA is found in 
high amounts in flaxseed, walnuts, perilla oil, canola oil and green leaves, particularly from wild 
plants (Simopoulos and Childs, 1990; Simopoulos, 2008). EPA and DHA are abundant in fish 
and fish oils (Hardman, 2004). Arachidonic acid (AA) is the other member of the omega-6 
family and can be synthesized from LA. Vegetable oils such as corn oil, sunflower, safflower 
and linseed oil are rich in LA (Simopoulos, 2008), whereas AA is abundant in red meat and red 
meat fat (Hardman, 2004). Western diets are low in omega-3 fatty acids and have excessive 
amounts of high omega-6 fatty acids, which may promote pathogenesis of many diseases 
including cancer (Simopoulos, 2008).  For example, mammary carcinogenesis was suppressed 
when equal parts of ω-6 and ω-3 fatty acids were fed to rats (Cohen et al., 1993; Sasaki et al., 
1998). An ω-6 / ω-3 ratio of about 1:1, as found in wild animals, is believed to be ideal for 
normal biological processes and is closer to the ratio on which humans evolved (Simopoulos et 
al., 1999; Simopoulos, 2008).  
 
Metabolism of omega-3 and omega-6 fatty acids and their effects on cancer 
Polyunsaturated fatty acids (PUFA) are essential components of structural membrane lipids. 
Both ω-3 and ω-6 PUFA are absorbed and integrated into cell membrane phospholipids either as 
consumed in the diet (Li et al., 1998), or they can be elongated and desaturated by delta 5- and 
delta 6-desaturases to form longer-chain PUFA, namely AA, EPA and DHA (Hagve and 
Christophersen, 1984 ; Denys et al., 2005) (Fig. 1.3). Humans and rodents can convert LA to AA 
and ALA to EPA and DHA but at a slow rate, and delta 6-desaturase is the rate-limiting enzyme 
in the synthesis of longer chain PUFA (de Gomez Dumm and Brenner, 1975). For example, the 
production of AA from LA is suppressed by ALA, EPA and DHA which outcompete LA for the 
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activity of the desaturases (Hagve and Christophersen, 1984). A study of human subjects by 
Cleland et al., (1992) showed LA to inhibit the incorporation of EPA from dietary fish oil 
supplements in neutrophil membrane phospholipids. However, decreasing the levels of LA with 
ALA in dietary fats was found to increase EPA level in plasma phospholipids in human (Liou et 
al., 2007). 
 
 
 
 
Fig 1.3. Synthesis of longer-chain omega-6 and omega-3 fatty acids.  
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Fatty acids released from membrane phospholipids are important cell signaling molecules 
(Simopoulos, 2008). Omega-3 and omega-6 fatty acids can be cleaved from cell membrane by 
phospholipase A2 (PLA2) for metabolism into eicosanoids by cyclooxygenase (COX) and 
lipoxygenase (LOX) enzymes (Denys et al., 2005). These eicosanoids induce signaling at the 
autocrine or paracrine level (Simopoulos., 2001). In most tissues cyclooxygenases (COX-1 and 
COX-2) can metabolize AA into the 2-series prostaglandins (including PGE2) and EPA into 3-
series prostaglandins (including PGE3). PGE2 favors cell proliferation while PGE3 is anti-
inflammatory and anti-proliferative (Al Olama et al., 2009; Yang et al., 2004). EPA is a better 
substrate for COX and can compete more successfully for COX activity than AA for the 
synthesis of prostaglandin (Yang et al., 2002; Needleman et al., 1979).  COX metabolites of ω-6 
fatty acids can stimulate angiogenesis (Rose and Connolly, 2000), whereas exposure to ω-3 fatty 
acids is able to suppress vessel formation via the inhibition of VEGF and VEGFR (Tsuzuki et 
al., 2007; Tsuzuki and Kawakami, 2008). Omega-3 fatty acid can inhibit NFkB activation and 
restore apoptosis in cancer cells (Hering et al., 2007).  
Several investigations have reported the decreased growth of various cancers due to 
consumption of an ω-3 diet. Kim et al., (1998) showed that colon cell proliferation was lower in 
rats fed ω-3 PUFA from fish oil compared to rats fed ω-6 PUFA from corn oil, and diets 
containing ω-3 PUFA from fish oil also decreased primary breast tumor growth and its 
metastasis in mice (Hubbard et al., 1998). Paulsen et al., (1998) reported that EPA and DHA 
inhibited the formation and growth of aberrant crypt foci during tumorigenesis in rat colon, and 
Chang et al., (1998) found fish oil enriched diet to lower the incidence of adenocarcinoma 
compared to a corn oil diet via increased apoptosis and differentiation.  Furthermore, Rose & 
Connolly (1991) showed that the PC-3 human prostate cancer cell line growth is stimulated when 
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treated with LA, whereas EPA and DHA inhibited its growth. Berquin et al., (2007) reported that 
omega-3 fatty acids reduced prostate tumor growth, slowed histopathological progression, and 
increased survival, whereas omega-6 fatty acids had opposite effects in a transgenic mouse 
model. PUFA can also interact with pro-oxidants to influence tumorigenesis as reported by 
Hardman et al., (1997), in which iron supplementation combined with ET-18-OCH3, a pro-
oxidative drug resulted in the slowest growth rate, lowest mitotic index, highest level of lipid 
peroxidation products and increased the cytotoxic index in implanted human breast tumors in 
mice consuming a fish oil diet. Furthermore, omega-3 and omega-6 fatty acids can rapidly and 
directly alter the transcription of some genes (Simopoulos, 1996). Simopoulos, (1996) showed 
that EPA and DHA suppressed the transcription of IL-1β, an inflammatory gene, while AA did 
not. 
Few studies have investigated the levels of plasma omega-3 and omega-6 fatty acids in 
humans. Bailey and Southon (1998) reported the following normal average plasma levels of 
omega-3 and omega-6 fatty acids in adult humans: ALA – 27.5µg/mL (98.8µmol/L), EPA – 
23.0µg/mL (76.0453µmol/L), DHA – 54.9µg/mL (166µmol/L); LA – 1221.0µg/mL 
(4353.7µmol/L), AA – 228.8µg/mL (751.47µmol/L).  A report by Harper et al., (2005) showed 
average plasma levels of ALA – 19.19µmol/L, EPA – 24.09µmol/L, DHA – 80.46µmol/L; LA – 
1487.31µmol/L, AA – 650.5 µmol/L in individuals with multiple illnesses that included 
hypertension and diabetes. Unpublished data from our laboratory showed that patients with early 
stage chronic lymphocytic leukemia (CLL) had average ALA – 74.97µmol/L, EPA – 
65.9µmol/L, DHA – 64.9µmol/L; LA – 2435.0µmol/L, AA – 666.4µmol/L in the plasma. After 
patients received omega-3 as fish oil supplements for 3 months, the plasma levels of the longer-
chain omega-3 fatty acids increased and omega-6 fatty acids decreased (ALA – 56.2µmol/L, 
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EPA – 296.4µmol/L, DHA – 188.5; LA – 1979.5µmol/L, AA – 444.9µmol/L). A study by 
Sekikawa et al., (2008) compared the normal serum levels of omega-3 and omega-6 fatty acids 
in Japanese in Japan and White Americans. These results showed the average proportions of 
individual fatty acids to total fatty acids in Japanese as ALA – 0.2%, EPA – 2.5%, DHA – 5.9%; 
LA – 26.8%, AA – 6.6%, and in American men as ALA – 0.3%, EPA – 0.8%, DHA – 2.4%; LA 
– 29.9%, AA – 9.0%. From these reports, the ratio of omega-6/omega-3 was higher in 
individuals with illnesses that included hypertension, diabetes and early stage CLL  
compared to normal individuals, and lower in Japanese who are known for lower incidence for 
cardiovascular diseases and cancer compared to Americans with higher incidence for 
cardiovascular disease and cancer.   
 
Breast cancer 
Breast cancer is the cancer that originates from breast tissue. Breast cancer can occur in both 
women and men but it is far more common in women than  in men (NCI, 2011). It is the most 
frequently diagnosed noncutaneous cancer and the leading cause of cancer death in females 
worldwide, accounting for 23% (1.38 million) of the total new cancer cases and 14% (458,400) 
of the total cancer deaths in 2008 (Jemal et al., 2011). The incidence rates are high in the 
Western world and lower in Asia (Jemal et al., 2011). Breast cancer is the most frequently 
diagnosed noncutaneous cancer and the second leading cause of cancer related death in women 
in US, accounting for 28% and 15% of total expected cancer incidence and death respectively  in 
women in 2010 (Jemal et al., 2010).  
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Breast cancer is a complex disease that involves the endocrinology of the female 
interacting with exogenous factors such as environmental chemicals, and lifestyle such as diet 
and obesity (Dewaard, 1992; Davies et al., 1997). ). Estrogen stimulates cell proliferation, which 
may lead to accumulation of random genetic errors that result in neoplasia (Henderson, 1993). 
The incidence of breast cancer increases with age with the majority of women diagnosed after 
the age of 40 years (Breast Cancer Facts & Figures, 2010). Early menarche and late menopause 
lead to an increased total lifetime number of menstrual cycles and increased estrogen exposure, 
thereby increasing the risk for breast cancer. In contrast, late menarche and early menopause lead 
to a reduction in breast cancer risk due to less exposure to estrogen (Vogel, 2000). The use of 
postmenopausal estrogen and progestin is associated with increased risk for breast cancer 
(Schairer et al., 2000), and in utero exposure to high estrogen level has also been reported to 
increase the risk (Potischman and Troisi, 1999). Nulliparity and late age at first birth increase the 
risk for breast cancer but pregnancy at a young age, especially before the age of 20, and early age 
at birth of a second child are associated with reduced risk (McPherson et al., 2000; Vogel, 2000).  
Breast cancer can be inherited as family history of the disease increases a woman’s own risk for 
breast cancer (Hankinson, 2004). About 10% of breast cancer in Western countries is attributed 
to genetic predisposition (McPherson et al., 2000). BReast CAncer1 and 2 (BRCA1 and 
BRCA2) genes account for most of the cases of familial breast cancer (McPherson et al., 2000). 
Individuals who harbor mutations in these genes have a 60% to 80% risk of developing breast 
cancer in their lifetimes (Malone et al., 1998). Treatments for breast cancer include surgery, 
hormonal therapy, chemotherapy, radiation and/or immunotherapy (Florescu et al., 2011) 
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Morphology of the mammary gland  
The female breast consists of the lobules which are involved in milk production, the ducts which 
convey milk from the lobules to the nipple, and the stroma which consists of fatty tissue, 
connective tissue, blood vessels, and lymphatic vessels (Fig. 1.4). Most breast cancers begin in 
the epithelial cells that line the ducts (ductal cancers). Some begin in the epithelial cells that line 
the lobules (lobular cancers), while a small number start in other tissues. Mammary gland 
development occurs throughout life beginning from childhood at a slow pace until the onset of 
puberty during which the process increases rapidly (Russo and Russo, 2004). 
  
 
Fig.1.4. Schematic view of mammary gland morphology (Reprinted by the 
permission of the American Cancer Society, Inc. from www.cancer.org. All rights reserved)    
 
Each ductal branch ends with zones of highly proliferative cells referred to as the 
terminal ductal lobular units (called terminal end buds in mice) which differentiate into 
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lobuloalveolar units (called alveolar buds in mice) during pregnancy and later stages of 
development (Russo and Russo, 2004). These highly proliferative structures are the initiation 
sites in tumorigenesis (Russo and Russo, 2004). Nulliparous women have predominantly 
undifferentiated structures in their breasts, whereas parous women have predominantly most 
differentiated structures in their breasts (Russo et al., 1992).  
Studies of cancer incidence in Asian-American women have strongly suggested that 
lifestyle and environmental factors such as diet are important factors that contribute to breast 
cancer risks (Davies et al., 1997). Asian women, with typically a lower rate of breast cancer and 
higher consumption of fish oil compared with Western women, experience an increase in 
incidence of breast cancer after emigration to the West, increasing to equal to the indigenous 
population level within a generation (Ziegler et al., 1993). Several studies have therefore 
suggested that timing of exposure to dietary intervention is important in modulating cancer risk 
at multiple stages such as in utero, prepuberty, puberty, pregnancy and lactation (Hilakivi-
Clarke, 2001; De and Hilakivi-Clarke, 2006; Lo et al., 2009). As treatment for breast cancer is 
sometimes unsuccessful or may be too late, and, where possible, the side effects are significant 
and distressing. Thus, preventing cancer is a desirable strategy.  
 
Breast cancer classification 
Breast cancer is classified into several categories according to multiple different schemes that 
describe each individual breast cancer in a way that helps select which treatment approach will 
yield the best outcome. A full classification includes histopathological type, grade of tumor, 
stage (TNM) of tumor, receptor status, and the presence or absence of genes as determined by 
DNA testing. 
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The commonly used grading system is the Bloom-Richardson-Elston grading system 
(Genestie et al., 1998), which examines the cells and tissue structure of the cancer to determine 
how aggressive and invasive the cancer is. Grade 1 tumor is well differentiated tumor with the 
best prognosis, grade 2 is moderately differentiated tumor with a medium prognosis and grade 3 
is poorly differentiated tumor with the worst prognosis. Lower grade tumors can be treated with 
less aggressive surgery and medication and have a better survival rate, whereas higher grade 
tumors require more aggressive surgery, radiation, and drugs, and have a worse survival rate. 
The TNM (tumor, node, metastasis) staging system describes the extent of cancer in a 
patient’s body (Denoix, 1946). It uses the size and extension of the primary tumor, its lymphatic 
involvement, and the presence of metastases to classify the progression of cancer. ‘T’ describes 
the size of the tumor and whether it has invaded nearby tissue, ‘N’ describes regional lymph 
nodes involved, and ‘M’ describes distant metastasis. The TNM descriptors are often combined 
into a single overall stage grouping number called Prognostic Group, labelled as Stage 0 to IV. 
Most Stage I tumors are curable whereas most Stage IV tumors are incurable. 
  Immunohistochemistry is used to identify the presence of estrogen receptors (ER), 
progestin receptors (PR) and Human Epidermal growth factor Receptor 2 (HER2) all of which 
are routinely assayed in breast cancers to determine the suitability of using targeted treatments 
such as tamoxifen, an antagonist of the estrogen receptor.  
DNA classification uses DNA microarrays for comparing normal cells to breast cancer 
cells to identify differences in gene expression levels for disease prognosis and to help determine 
therapeutic strategies (Sparano and Solin, 2010).  
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Prostate cancer 
Prostate cancer is a cancer that develops in the prostate of the male reproductive system. It is the 
second most common noncutaneous cancer in men worldwide and the sixth leading cause of 
cancer death in males (Jemal et al., 2011). It accounted for 14% (903,500) of the total new 
cancer cases and 6% (258,400) of the total cancer deaths in males in 2008 (Jemal et al., 2011). 
The incidence of prostate cancer is highest in the developed nations of North America, Europe, 
and Oceania, and lowest in Asia (Jemal et al., 2011). In the US, prostate cancer remains the most 
frequently diagnosed noncutaneous cancer and the second leading cause of cancer related death 
among men, accounting for 28% of total expected cancer incidence in men in 2010 (Jemal et al., 
2010). The risk for prostate cancer increases with age and is common among men aged 65 and 
above (Gronberg, 2003).  Prostate cancer, in most cases, is slow-growing but can also be fast 
developing and aggressive and may metastasize from the prostate to other parts of the body, 
particularly bones and lymph nodes. Conventional treatment regimens include  active 
surveillance (monitoring for tumor progress or symptoms), radical prostatectomy, radiation 
therapy, chemotherapy, hormonal therapy, or some combination of these modalities.  
Prostate cancer can be caused by genetic factors which may be inherited (Al Olama et al., 
2009). Men with a family history of prostate cancer have a higher risk of developing the cancer. 
There is also the shared familial risk for prostate and breast cancers. For example, mutations in 
the BRCA-2 gene (Breast Cancer 2 susceptibility gene) increase the risk for prostate cancer that 
is more aggressive and develops at a younger age (Cancer Facts and Figures, 2010). Some 
epidemiologic and more experimental studies have reported that nutrition also plays a role in the 
development of prostate cancer. Consumption of high fat diets is associated with high risk for 
prostate cancer (Kolonel et al., 1981; Giovannucci et al., 1993). A study by Ritch et al., (2007) 
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found that omega-6 fatty acids stimulated prostate cancer cell growth, whereas omega-3 fatty 
acids inhibited cancer cell growth in Jamaican men known for high consumption of omega-6 
fatty acids and with the highest incidence of prostate cancer. A possible protective role in 
reducing prostate cancer has also been reported for foods containing Vitamin B6 (Kasperzyk et 
al., 2009), selenium, vitamin E, lycopene, and soy (Lee et al., 2003).  
Although treatment for prostate cancer has advanced greatly, the cost is enormous and 
treatment is not very effective. Identifying and establishing dietary factors that may reduce the 
risk for prostate cancer will no doubt reduce the human and economic burden for its treatment. 
 
Anatomy and histology of the human and mouse prostate 
The human prostate lacks discernible lobular structure, but it is described as a zonal architecture 
consisting of the central, transition, and peripheral zones, together with an anterior fibromuscular 
stroma (McNeal, 1988, Timms, 2008) (Fig. 1.5A). The peripheral zone occupies the most 
volume and harbors the majority of prostate carcinomas (Shappell et al., 2004). In contrast to the 
human prostate, the mouse prostate consists of multiple lobes corresponding to the anterior, 
ventral, lateral and dorsal lobes (Fig. 1.5B). The dorsal and lateral lobes are often combined and 
referred to as the dorsolateral lobe, which is most homologous to the human peripheral zone 
(Shappell et al., 2004).   
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Fig. 1.5. Schematic view of the anatomy of the human and mouse prostate (Cory Abate-
Shen and Michael M. Shen, Genes & Dev., 2000. With kind permission of Cold Spring 
Harbor Laboratory Press) 
 
 
Histologically, both the human and mouse prostate contain a pseudostratified epithelium 
with three differentiated epithelial cell types: luminal, basal, and neuroendocrine (Shappell et al., 
2004) (Fig. 1.6). 
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Fig. 1.6. Schematic view of the cell types in the human and mouse prostatic duct (Cory 
Abate-Shen and Michael M. Shen, Genes & Dev., 2000. With kind permission of Cold 
Spring Harbor Laboratory Press) 
 
The luminal epithelial cells form a continuous layer of columnar cells that produce protein 
secretions. Basal cells and the neuroendocrine cells are located beneath the luminal epithelium.  
The neuroendocrine cells are rare cells in the normal prostate. 
 
Hormone responsiveness in prostate cancer 
Androgen and estrogen are involved in the normal development of the prostate as well as in 
prostate cancer pathogenesis (King et al., 2006). The most abundant androgen is testosterone, 
which is produced mostly by the testis. Additional testosterone can be synthesized in the adrenal 
gland.  Testosterone is converted into the more potent metabolite dihydrotestosterone (DHT) in 
prostate tissue through the activity of 5α-reductase. The direct effect of androgen is mediated by 
the androgen receptor (AR). The dependency of prostate tissue on androgen is manifested by 
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rapid cell apoptosis and regression following androgen withdrawal (Watson et al., 2005; Gao et 
al., 2004). Circulatory estrogens are produced in a very low amount in the testis. Estrogen may 
also be produced locally within the prostate via conversion of testosterone to estrogen by the 
aromatase enzyme (Risbridger et al., 2003). The direct effects of estrogen on prostate are 
mediated through estrogen receptors (ER) ( Griffiths et al., 1997; Bohnsack and Hirsch, 2004; 
Omoto, 2008) and indirectly by increasing the sensitivity of the prostate tissue to low levels of 
testosterone via up-regulation of the androgen receptor (Moore et al.. 1979; Richer et al 2007). 
Estradiol is reported to induce high-grade PIN and prostate cancer in the aging dog (Ho, 2004) 
whereas toremifene, an antiestrogen, prevented prostate cancer in mouse (Raghow et al., 2002). 
 
Pathological classification of prostate cancer  
Most prostate cancers are adenocarcinoma (Shen and Shen, 2010). Prostatic intraepithelial 
neoplasia (PIN) is the precursor for prostate cancer (Shappell et al., 2004) (Fig. 1.7). PIN can be 
classified as low-grade PIN (LGPIN) or high-grade PIN (HGPIN). The histology of PIN is 
characterized by epithelial hyperplasia, enlargement of nuclei and nucleoli, cytoplasmic 
hyperchromasia, and nuclear atypia (Shappell et al., 2004).  
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Fig. 1.7. Schematic illustration of prostate cancer progression (Cory Abate-Shen and 
Michael M. Shen, Genes & Dev., 2000. With kind permission of Cold Spring Harbor 
Laboratory Press) 
 
Histopathological grading of prostate tissue is done by Gleason grading system (Gleason and 
Mellinger, 1974), which evaluates the tumor’s degree of differentiation and anaplasia. The shape, 
size and staining properties, as well as whether they are well, moderately or poorly differentiated 
cells, are taken into account. The Gleason score ranges between 1 and 10. Well differentiated 
cells are given Gleason score 1, score 2 – 4 is low grade, score 5 – 7 is moderate, and score 8 – 
10 is a high grade tumor. 
 
Mouse model 
The C3(1) TAg transgenic mouse model, developed in Dr Jeffrey Green’s laboratory of the 
National Cancer Institute, was chosen in our intervention studies because mammary and prostate 
cancers from these mice are histologically similar to human breast and prostate cancers 
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respectively (Green et al., 2000). This model has been used to study omega-3 intervention 
against tumorigenesis in the mammary gland and well as in the prostate. 
 The mice carry the C3(1)SV40 TAg construct in which the C3(1) rat prostate steroid 
binding protein promoter drives the expression of the SV40 large T (TAg) in the epithelium of 
the mammary and prostate glands (Maroulakou et al.,1994). SV40 TAg induces transformation 
and tumorigenesis by binding to and functionally inactivating p53 and Rb (Mietz et al., 1992; 
Dyson et al., 1989). Male and female hemizygotes were generated by crossing the C3(1) TAg  
mice (having FVB/N background) and SV129 wild type female mice to obtain C3 (1)TAg/129 
hemizygote offspring . Female hemizygotes developed hyperplasia in the mammary duct at 3 
months of age, progressing to adenocarcinoma at 4 months. Metastasis to the lung occurred by 6 
months.  This model has been successfully used in studies of chemoprevention of mammary 
tumorigenesis (Green et al., 2000).  
The homozygous male transgenic mice developed prostatic hyperplasia by 3 months 
which progressed to adenocarcinoma by 7 months (Maroulakou et al.,1994). Prostate cancer 
metastases to lung occurred after 8 months (Maroulakou et al., 1994). Hemizygous 
FVB/C3(1)TAg male mice developed prostatic intraepithelial lesion (PIN) that histologically 
resembled those found in human PIN (Shibata et al., 1996). Low-grade PIN appeared at 2 
months and progressed to high grade at 5 months, and prostate carcinomas developed after 7  
months (Shibata et al., 1996). The C3(1)/TAg transgenic model develops prostate cancer slowly 
and has a well characterized disease progression ( Shibata et al., 1996), which makes it well 
suited for prevention studies.  
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STUDY OBJECTVES 
The main objectives of our studies were to determine whether increasing omega-3 and 
decreasing omega-6 fatty acids via consumption of diets that contain canola oil, walnut or fish oil 
supplements instead of corn oil will slow the development for breast cancer and prostate cancer 
in our transgenic mouse model. In chapter two, we investigated whether increasing omega-3 and 
reducing omega-6 fatty acids using canola oil instead of corn oil in the maternal diet might 
reduce the risk for breast cancer in female offspring. We found this change to the maternal diet 
suppressed tumorigenesis in the mammary glands of the offspring. In chapter three, we 
investigated whether regular walnut consumption might reduce the risk for developing breast 
cancer. We found that consumption of an equivalent of 2 servings of walnut per day slowed 
mammary gland tumorigenesis. In chapter four I investigated whether changing from corn oil 
diet to a fish oil-supplemented diet at adulthood might reduce the risk for prostate cancer. We 
found that consumption of fish oil-supplemented diet suppressed prostate tumorigenesis.  
 In all of these studies, we showed that a shift from a diet with a high omega-6/omega-3 
ratio, as prevalent in Western diets, to lower omega-6/omega-3 diets was beneficial for 
suppressing breast and prostate cancers in these mice. The diets were chosen to be an easy 
change for humans to make. Such changes may be beneficial for reducing the risk for breast and 
prostate cancer in humans.  
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Abstract 
 
Background 
Maternal consumption of a diet high in omega-6 polyunsaturated fats (n-6 PUFA) has been 
shown to increase risk whereas a diet high in omega-3 polyunsaturated fats (n-3 PUFA) from 
fish oil has been shown to decrease risk for mammary gland cancer in female offspring of rats. 
The aim of this study was to determine whether increasing n-3 PUFA and reducing n-6 PUFA by 
using canola oil instead of corn oil in the maternal diet might reduce the risk for breast cancer in 
female offspring.  
Methods 
Female SV 129 mice were divided into two groups and placed on diets containing either 10% 
w/w corn oil (which is 50% n-6 PUFA, control diet) or 10% w/w canola oil (which is 20% n-6 
PUFA, 10% n-3 PUFA, test diet). After two weeks on the diets the females were bred with 
homozygous C3(1) TAg transgenic mice. Mother mice consumed the assigned diet throughout 
gestation and nursing of the offspring. After weaning, all female offspring were maintained on 
the control diet.  
Results 
Compared to offspring of mothers fed the corn oil diet (CO/CO group), offspring of mothers fed 
the canola oil diet (CA/CO group) had significantly fewer mammary glands with tumors 
throughout the experiment. At 130 days of age, the CA/CO group had significantly fewer tumors 
per mouse (multiplicity); the tumor incidence (fraction of mice with any tumor) and the total 
tumor weight (per mouse that developed tumor) was less than one half that of the CO/CO group. 
At 170 days of age, the total tumor weight per mouse was significantly less in the CA/CO group 
and if a tumor developed the rate of tumor growth rate was half that of CO/CO group. These 
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results indicate that maternal consumption of canola oil was associated with delayed appearance 
of mammary gland tumors and slowed growth of the tumors that developed. 
Conclusions 
Substituting canola oil for corn oil is an easy dietary change for people to make; such a change to 
the maternal diet may decrease risk for breast cancer in the daughter.  
 
 
Background 
 
It has been shown that diets that contain high amounts of omega-6 polyunsaturated fatty acids 
(PUFA) increase the growth rates of cancers (Rose and Hatala, 1994) whereas omega-3 PUFA 
have been shown to reduce cancer growth rates ( Rose and Connolly, 1993)  and have been 
suggested as cancer preventive agents (Rose, 1997). The type of fat consumed by the mother 
during pregnancy and nursing of the offspring has also been shown to influence mammary gland 
cancer risk in the offspring. A maternal diet that contained a high (versus low) amount of omega- 
6 fatty acids increased the risk for mammary gland cancer in the carcinogen-treated offspring 
(Hilakivi-Clarke et al., 1997). Compared to a corn oil diet, maternal consumption of either an 
olive oil containing diet (high in omega 9 fatty acid) (Stark et al., 2003) or of a diet containing 
long chain omega 3 PUFA from fish oil (Hilakivi-Clarke et al., 2002) has been shown to 
decrease carcinogen-induced mammary gland cancer in rat offspring. We have reported that the 
18 carbon omega-3 PUFA found in canola oil also effectively slowed the growth of implanted 
mammary gland cancers (Hardman, 2007). We hypothesized that a maternal diet that contained 
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canola oil instead of corn oil would increase maternal dietary omega 3 PUFA and thus reduce the 
risk for mammary gland cancer in the offspring. 
The C3(1) SV40 T-antigen transgenic mouse was selected as the model for this study. 
This mouse is a well characterized model developed in the laboratory of Dr. Jeffrey E. Green 
(jeffrey.green1@nih.gov). The transgene uses the 5’ flanking region of the rat C3(1) prostate 
steroid binding protein to target expression of the SV 40 large T-antigen in the mammary gland 
and prostate (Green et al., 2000). The female mice develop invasive mammary gland tumors by 
16 weeks of age (Green et al., 2000). The tumors are similar to human infiltrating ductal 
carcinomas, are hormone responsive at early stages but become hormone independent in later 
stages (Green et al., 2000) similar to advanced human breast cancers. The lesions develop in a 
predictable time, thus, this mouse is a good model to study alterations in tumorigenesis and 
progression (Green et al., 2000). The T-antigen is thought to induce cancer by inactivation of 
p53 (Mietz et al., 1992) and Rb (Dyson et al., 1989), two proteins that are involved in cell cycle 
regulation. Both p53 and Rb are tumor suppressors and are frequently mutated in human breast 
cancer. Because the mouse has a strong transgenic tumor promoter, complete prevention of 
tumors would not be expected but a delay in tumor development or slower tumor growth 
compared to a control group would indicate cancer preventive benefit. 
Most studies that have tested effects of omega 3 fatty acids on cancer have used the long 
chain omega 3 fatty acids, eicosapentaenoic (EPA, 20 carbons, 5 unsaturations) or 
docosahexaenoic (DHA, 22 carbons, 6 unsaturations) as the test fatty acids (Cave,1991; Clarke et 
al., 1999; Germain et al., 1999; Chen and Istfan, 2000; Hardman et al., 2002). These fatty acids 
are most commonly found in fish, thus fish oil or fish oil concentrates are frequently 
incorporated into diets. However, the double bond in the omega-3 position is produced by plants, 
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not by animals, and can be found in plant products as the 18 carbon fat, α-linolenic acid (ALA). 
Good dietary sources of ALA include canola oil, walnuts and “omega-3 eggs” (Bourre, 2007). 
Flaxseed or flaxseed oil is also a good source of ALA (Demark-Wahnefried et al., 2001) but is 
often consumed as a dietary supplement rather than a part of the regular diet. Canola oil contains 
about 10% ALA and about 20% linoleic acid (LA), an 18 carbon omega 6 fatty acid (USDA, 
2009), whereas corn oil contains about 50% LA and about 1% ALA (USDA, 2009). A ratio of 
omega-3 to omega-6 fatty acids of somewhere between 1:1 and 1:4 has been suggested to be 
much healthier than the 1:10 to 1:25 ratio of omega-3 to omega-6 fatty acids contained in the 
usual Western diet (Simopoulos, 1991).  
The ALA that is consumed by animals (whether fish, mouse or human) may be 
metabolized without change or it may be elongated and desaturated to longer chain lipids of the 
omega-3 series (Simopoulos, 1991). Humans elongate and desaturate ALA. However, there is 
controversy about the efficiency of this conversion (Simopoulos, 1991). Recent reports indicate 
that humans do convert ALA to measurable amounts of EPA and docosapentaenoic acid (22 
carbons, 5 unsaturations, omega-3, DPA) and that the conversion is adequate to reduce measures 
of inflammation, indicating biologic activity of the omega 3 fatty acids in humans ( Zhao et al., 
200;  Zhao et al., 2007). Long chain omega-3 PUFA incorporated in tissues have been shown to 
slow cancer growth in animal models by multiple mechanisms, including slowing proliferation, 
increasing apoptosis (Rose et al., 1995), increasing lipid peroxidation (Hardman et al., 2002) and 
increasing oxidative damage in cancer cells but not normal cells (Hardman et al., 2002). 
Induction of these mechanisms is correlated with an increased amount of the omega-3 PUFA in 
the tissues. 
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Johnson et al., (2007) used data from the National Health and Nutrition Survey, 1999-
2002, to estimate the actual consumption of ALA and LA in the average American diet. They 
report that the usual diet of adult Americans contains about 14.7 g of LA and about 1.5 g of ALA 
per day (Johnson et al., 2007), almost 10 times as much LA as ALA. They estimated that, if 
Americans replaced vegetable oils, butter, and margarine with canola oil or canola oil based 
margarine, the intakes of ALA would increase to 2.6 g per day and of LA would decrease to 8.1 
g per day (Johnson et al., 2007). This would change the ratio of these omega-3 and omega-6 fatty 
acids in the diet to about 1:3, a much healthier ratio that would better meet current dietary fat 
recommendations (Johnson et al., 2007).  
We have shown that the use of canola oil as a source of omega-3 PUFA significantly 
slowed the growth rate of MDA-MB 231 human breast cancers implanted in nude mice and that 
the decreased tumor growth rate was associated with increased long chain omega-3 PUFA in 
mouse tissues (Hardman, 2007).There is a suggestion that canola oil use may be beneficial 
against cancer in humans in that women who used canola oil for cooking had a lower risk for 
breast cancer than those who used hydrogenated fats or corn oil (Wang et al., 2008). The use of 
canola oil instead of corn oil is a diet change that would be easy to make because canola oil 
could be substituted for corn oil in baking, frying and salad dressings. Our results indicate that 
such a dietary change could result in important health benefits, perhaps decreasing risk for 
cancer in the next generation. 
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Methods 
 
Animals  
Twenty female SV129 mice, 6 weeks old were obtained from Charles River Laboratories 
(Wilmington, MA). Breeding pairs of mice bearing a transgene for the SV40 large T antigen 
with a C3(1) rat prostate steroid binding protein promoter were obtained from the Dr. Jeffrey 
Green. The female transgenic mice are expected to develop mammary gland cancer due to 
expression of the large T antigen in the mammary gland (Maroulakou et al., 2001). The 
transgenic line is maintained in the laboratory and all mice are genotyped to ensure presence of 
the transgene. All animal work was approved by the Marshall University School of Medicine 
Institutional Animal Care and Use Committee.  
Study design 
Mice were quarantined for 2 weeks and then moved to a study room. SV129 females were split 
into 2 groups and numbered for identification. Ten female mice were placed on a diet containing 
10% w/w corn oil (control diet, see below) and ten female mice were placed on a diet containing 
10% w/w canola oil (test diet). After 2 weeks these females were bred with homozygous 
C3(1)/TAg male mice. The hemizygous female pups from these breedings were the experimental 
mice NOT the wild type mother mice. Pups were weaned at 21 days old and placed on the corn 
oil containing diet, generating two experimental groups: corn/corn (CO/CO) and canola/corn 
(CA/CO) (the first diet is the maternal diet, the second diet is the pup’s diet). Only the maternal 
diet of the CA/CO group contained canola oil, not the diet of the experimental pups. The 
offspring were housed 3 to 4 in a cage, individually numbered for identification, and weighed 
weekly.  
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Diet  
Diets were prepared in the Marshall University School of Medicine animal diet prep room. Diet 
composition is shown in Table 2.1 and was formulated to be isocaloric, isonutrient and more 
relevant to human consumption than the high fat diets used in many studies. (If a Western diet 
contains about 14.7g of LA/day (Johnson et al., 2007) the calories from LA are 6.6% of a 2000 
calorie diet. The 10% corn oil mouse diet contained 10.9% of calories from LA.) The AIN-76A 
diet is adequate for the nutritional support of the mice (American Institute of Nutrition, 1977). 
The dry ingredients of the diet, except sugar, were obtained in bulk from MP Biomedicals  
(Solon, Ohio), and sugar and oil were purchased locally (100% canola oil or 100% corn oil, no 
additives or preservatives). Batches of diet were prepared as needed, about every two weeks.  
Table 2.1  Composition of the diets 
Ingredient % of wt Amount /100g Calories/100g 
Casein (protein) 20% 20 g 80 
Sucrose 45% 45 g 180 
Corn starch 
(carbohydrate) 
15% 15 g 60 
Alphacel (fiber) 5% 5 g 0 
Choline bitartrate 0.2% 0.2 g 0 
DL-methionine 0.3% 0.3 g 0 
Mineral mix 3.5% 3.5 g 0 
Vitamin mix 1.0% 1 g 0 
Oil (fat) either corn oil 
or canola oil 
10% 10 g 90 
Total  100% 100 g 410 
 Total fat   10g 90 
Total protein  20g 80 
Total carbohydrate  60g 240 
The AIN-76A was slightly modified to contain 10% w/ w corn oil (control diet) or 10% w/w canola oil 
(test diet). Control and canola diets were balanced for calories, nutrients, protein, fat and carbohydrate. 
The AIN-76A diet is adequate for growth and nutrition of mice. 
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The diet mixture was pressed into trays and cut into small squares. Individual cage sized portions 
(25-30 g) were stored in sealed containers at -200C to prevent oxidation of the fat and bacterial 
growth in the food. Mice had free access to food and water and were fed fresh food 5 days per 
week. Food removed from cages was discarded. 
Transgene copy number 
Real time PCR was used to verify the presence of the transgene in all experimental pups. Ear 
punches (two 2 mm punches, stored at -200C until processing) were digested in digestion buffer 
[50mM KCl, 1.5mM MgCl2, 10mm Tris pH 8.5, 0.01% Gelatin, 0.45% NP-40, 0.45% Tween 20 
containing 140mg/ml proteinase K (Shelton Scientific, Shelton, CN)], followed by dilution of the 
samples 1:40 in milliQ water (Milli-Q Advantage, Millipore, Massachusettes). Primers for the 
transgene (SV40 foward: ATA TGC CTT CAT CAG AGG AAT ATT C; SV40 reverse: TAA 
AGT TTT AAA CAG AGA GGA ATC TTT GC) and the VIC labeled SV40PROBE (VICCCC 
AGG CAC TCC TTT CAA GAC CTA GAA GGMGBNFQ) were purchased from Applied 
Biosystems (Foster City, CA). Beta-actin primers (for an internal control) and PCR Master Mix 
were also purchased from Applied Biosystems. The rtPCR assay was performed according to the 
Applied Biosystems instructions on an ABI Prism 7000 (Applied Biosystems, Foster City, CA) 
instrument. 
 
Tumor growth rates, incidence, multiplicity and weight 
Mice were palpated for tumors 3 times weekly from 90 days of age. Lengths and widths of 
palpable tumors were measured from the time of detection until euthanasia to estimate tumor 
volumes. Tumor volume was estimated using the formula: (Length X Width X Width) /2. Prism© 
software (Graphpad, Inc., La Jolla, CA) was used to plot tumor growth curves and for regression 
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analyses to determine the growth rate of each palpable tumor. A T-test was then used to compare 
the mean tumor growth rates between groups of mice. Total tumor incidence, multiplicity and 
weights were determined at necropsy. The differences between groups and across time were 
statistically analyzed by two way analyses of variance, T-test, Fisher exact test or Mann-Whitney 
test as appropriate using Prism© software. 
 
Necropsy 
Mice were euthanized at 21, 110, 130, 150 and 170 days of age. Twenty one days of age was the 
time of weaning. The earliest time for tumors was expected to be 110 days of age, mice were 
euthanized each 20 days thereafter to follow the increase in tumor incidence and multiplicity. 
The left 4th mammary gland was quickly removed and frozen in liquid nitrogen. All ten 
mammary glands were examined for the presence of a tumor 1 mm or larger. All tumors detected 
were measured, removed and weighed, thus total tumor weight and numbers includes many 
tumors that were too small to be detected by palpation. If tumor was large enough for further 
assay, it was flash frozen in liquid nitrogen. The number of tumors in each gland and the number 
of glands with tumor were recorded for every mouse. Samples of inguinal fat and liver were 
removed and frozen in liquid nitrogen until further analyses.  
 
Body weights 
Body weights were measured each week and terminally. Statistical differences in mean body 
weight change between groups were determined using a T-test and Prism© (Graphpad, Inc) 
software.  
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Gas chromatography  
The fatty acid compositions of mammary glands and liver at 3 weeks of age and 130 days of age 
were analyzed by gas chromatography. Frozen tissues were thawed and homogenized in distilled 
water containing 0.1% BHT to prevent oxidation of the fatty acids. Lipids were extracted with 
chloroform/methanol, the fatty acids were methylated followed by separation and identification 
using gas chromatography, as previously described (Hardman, 2007). Gas chromatography was 
done using a PerkinElmer Clarus 500 Gas Chromatograph (Shelton, CT) with a Elite-5 (5% 
Diphenyl) Dimethyl-polisiloxane Series Capillary Column (Length: 30m, Inner Diameter: 
0.25mm), under the following conditions: initial temperature 1500C, ramp 1 at 1750C for 15min, 
ramp 2 at 2250C for 50min, ramp 3 at 2500C for 10min, helium carrier gas flow rate of 
1.60ml/min. Fatty acid methyl ester standards (Nu-Chek-Prep, Elysian, MN) were used for peak 
identification. For a better identification of the peaks two standards were used: GLC #464 which 
contains 52 fatty acids and a custom preparation, GLC #704, which contains 10 fatty acids, 
methyl esters of stearate, oleate, linoleate, alpha linolenate, gamma linolenate, homogamma 
linolenate, arachidonate, eicosapentaenoate, docosapentaenoate, and docosahexaenoate. The fatty 
acid methyl esters were reported as the percent of the total methylated fatty acids (area under the 
curve). Using this protocol and column, we could not clearly separate the oleic acid (18:1n-9) 
and alpha linolenic acid (ALA 18:3n-3) peaks thus we report these results as 18:1 + 18:3 ALA. 
However, the differences in the peaks due to diet should be mostly ALA since it is the dietary 
ALA that was altered. A T-test was used to determine statistical differences of individual fatty 
acids between dietary groups.  
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Gene expression assay  
The Mouse Signal Transduction Pathway Finder™ RT² Profiler™ PCR Array, PAMM-014 
(SuperArray Bioscience Corporation, Frederick, MD) was used to analyze the expression of 
genes in 3-4 mammary glands per group at 130 days of age mice. (The complete list of genes on 
the plate can be found at http://www.sabiosciences.com/rt_pcr_product/HTML/PAMM-
014A.html.) Frozen tissue was homogenized in Tri Reagent (Sigma-Aldrich, St. Louis, Mo) 
following the protocol of the manufacturer to isolate the RNA. RNA quality control was 
performed for all samples to insure the purity and integrity of the RNA on an Agilent 2100 
Bioanalyzer (Santa Clara, CA). The RT2 First Strand Kit was used to make cDNA; the cDNA 
was then quantitatively amplified by real time PCR using an ABI Prism 7000 (Applied 
Biosystems, Foster City, CA) and RT2 qPCR Master Mix (Superarray) according to the 
manufacturer’s protocol. The protocol and software provided by SuperArray were followed to 
determine relative fold difference in gene expression using the ∆∆ct method and for statistical 
analyses of the data by T-test.  
 
Immunoblot analysis  
Frozen mammary gland tissues were homogenized in tissue extraction buffer (50mM Tris, pH 
7.4, 250mM NaCl, 5Mm EDTA, 2mM Na3VO4, 1mM NaF, 20mM Na4P2O7, 0.02% NaN3 and 
proprietary detergent) from BioSource International, Inc. at 4oC to prepare cell lysates. Protein 
concentration was determined by BCA protein Assay Kit (EMD Biosciences, Inc. Darmstadt, 
Germany) following the manufacturer’s protocol. Ten micrograms of protein were applied to 
each lane of a 4-15% Tris-HCl polyacrylamide gradient gel (Bio-Rad, Hercules, CA), separated 
by electrophoresis and then transferred onto a nitrocellulose membrane. The blots were blocked 
with 5% BSA in TBST overnight at 4oC and probed with primary antibodies against [CCAAT-
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enhancer binding proteins β (C/EBP β) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), fatty 
acid synthase (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), glyceraldehyde 3 phosphate 
dehydrogenase (GAPDH) (CHEMICON International, Billerica, MA) or cytokeratin 8 (Santa 
Cruz Biotechnology, Inc., Santa Cruz, CA,)] in blocking buffer for 1 hour at room temperature. 
The membrane was thereafter incubated with antimouse (Santa Cruz Biotechnology, Inc.) 
secondary antibody horseradish peroxidase (HRP) conjugate followed by signal detection with 
chemiluminescence ECL Kit (PIERCE, Inc.). Densitometry was used to quantify bands. A 
ChemDoc XRS system (Bio-Rad Laboratories Inc., Hercules, CA) was used to acquire the image  
then image analysis was done using ‘Quantity One’ software, V. 4.5.2 (Bio-Rad Laboratories 
Inc., Hercules, CA). Data was normalized by cytokeratin (for size of the epithelial compartment) 
and by GAPDH (for protein loading). 
 
 
Results 
Group nomenclature 
Groups will be referred to as: 1) CO/CO – mothers fed the 10% corn oil diet, pup weaned to the 
10% corn oil diet or 2) CA/CO – mothers fed the 10% canola oil diet, pups weaned to the 10% 
corn oil diet. Pups were NOT exposed to the 10% canola oil diet after weaning. 
Body weight gain 
Mice were allowed free access to food. There was no difference due to maternal diet in the 
amount of weight gained between weaning and 170 days of age by the groups of experimental 
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mice (p=0.95 by T-test). Figure 2.1 shows the mean amount of weight gained per mouse per day 
from weaning until 170 days. 
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Fig. 2.1 Mean body weight gain between 21 and 170 days of age. Body weight gain between 
21 and 170 days of age was determined for each mouse. There was no significant difference 
between the two groups in body weight gain between weaning (21 days) and 170 days of age. 
CO/CO n=14; CA/CO n=17 mice, p=0.95 by T-test. 
 
 
Diet influence on tissue lipid composition 
The lipid compositions of the livers and mammary glands at 21 and 130 days of age are shown in 
Table 2.2.  
At 21 days of age (the time of weaning), both the livers and the mammary glands of pups 
from the CA mothers contained significantly less (p<0.05 by T-test) of the n-6 PUFA (LA and 
AA) than the livers and mammary glands of pups from the CO mothers. 
At 21 days of age, the livers of pups from the CA mothers contained significantly more 
(p<0.05 by T-test) of the omega-3 PUFA, ALA, and significantly more (p<0.05 by T-test) of the 
36 
 
products of ALA metabolism, EPA and DHA than the livers of pups from the CO mothers. The 
only source of the omega-3 bond was the ALA in the canola oil. Thus, the ALA in the canola oil  
 
Table 2.2  Major omega 6 and omega 3 fatty acids in tissues of mice.  
 Liver 21 days  
Fatty acid Corn oil diet Canola diet p value 
18:2 LA 17.35 ± 1.22 12.10 ± 0.90 <0.0001* 
18:1+18:3 ALA 9.59 ± 2.16 20.29 ± 2.04 <0.0001* 
20:4 AA 18.40 ± 1.60 10.08 ± 0.57 <0.0001* 
20:5 EPA 0.09 ± 0.02 1.39 ± 0.20 <0.0001* 
22:6 DHA 5.04 ± 0.81 11.22 ± 0.46 <0.0001* 
22:5 DPA 0.64 ± 0.08 0.53 ± 0.06 0.023* 
 Liver 130 days  
18:2 LA 23.96 ± 2.74 22.91 ± 0.93 0.5565 
18:1+18:3 ALA 18.19 ± 2.47 24.14 ± 1.01 0.0289* 
20:4 AA 13.82 ± 0.46 10.33 ± 0.49 0.0041* 
20:5 EPA 0.045 ± 0.04 0.10 ± 0.04 0.2382 
22:6 DHA 5.37 ± 0.49 3.83 ± 0.17 0.0127* 
22:5 DPA 0.315 ± 0.04 0.24 ± 0.03 0.0817 
 Mammary gland 21 days  
18:2 LA 26.25 ± 1.32 6.74 ± 1.99 0.0000* 
18:1+18:3 ALA 29.26 ± 0.70 50.99 ± 1.98 0.0000* 
20:4 AA 0.67 ± 0.12 0.31 ± 0.11 0.0043* 
20:5 EPA 0.06 ± 0.01 0.08 ± 0.05 0.4050 
22:6 DHA 0.08 ± 0.02 0.02 ± 0.01 0.0008* 
22:5 DPA 0.01 ± 0.01 0.06 ± 0.03 0.0124* 
 Mammary gland 130 days  
18:2 LA 37.15 ± 0.78 35.77 ± 2.30 0.2879 
18:1+18:3 ALA 0.40 ± 0.01 0.38 ± 0.03 0.1996 
20:4 AA 0.13 ± 0.01 0.11 ± 0.03 0.3218 
20:5 EPA 0.02 ± 0.01 0.00 ± 0.00 0.0000* 
22:6 DHA 0.01 ± 0.00 0.01 ± 0.01 0.2415 
22:5 DPA 0.02 ± 0.00 0.00 ± 0.00 0.0000* 
 
*values in row are significantly different by T-test 
 
was effectively elongated and desaturated to the longer chain omega 3 PUFAs, EPA and DHA, 
for incorporation into lipids in the liver.  
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At 21 days of age, the mammary glands of pups from the CA mothers contained 
significantly more (p<0.05 by T-test) ALA and DPA than the pups from the CO mothers. The 
content of the longer chain fatty acids; AA, EPA, DHA and DPA, in the mammary glands of 
both groups was less that 1% each indicating less incorporation of long chain fatty acids or less 
activity of elongation and desaturation enzymes in the mammary glands than in the liver. 
All mice were fed the corn oil diet from 21 to 130 days of age. At 130 days of age the 
livers of the CA/CO group still contained significantly more (p<0.05 by T-test) ALA (n-3 
PUFA) and significantly less (p<0.05 by T-test) AA (n-6 PUFA) than the CO/CO group. The 
LA, ALA, and AA in the mammary glands of the two groups were not different. EPA, DHA and 
DPA were almost undetectable in the mammary glands at 130 days of age, though the small 
differences between groups for EPA and DPA were statistically significant. Both EPA and DHA 
were significantly less (p<0.05 by T-test) in the mammary glands of the CA/CO than in the 
CO/CO group. 
 
Effect of maternal consumption of canola oil instead of corn oil on tumor multiplicity, 
incidence and growth  
The total number of tumors and the tumor weight per mouse were assessed in C3(1)TAG/129 
female offspring at 110, 130, 150, 170 days of age . The presence of the transgene was 
confirmed in all pups used in the experiment (data not shown).  
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Fig. 2.2. - Tumor incidence and multiplicity at 130 days of age. A) Tumor incidence (fraction 
of mice with any tumor) at 130 days of age was not quite significantly different due to the diet of 
the mother. CO/CO – 7 of 14 mice had tumors, CA/CO – 4 of 17 mice had tumors. Fisher’s exact 
test, p=0.1.  B) Tumor multiplicity, the mean number of tumors per mouse at 130 days of age.  
There were significantly fewer tumors per mouse by Mann-Whitney, p<0.001.  CO/CO n=14 
mice; CA/CO n=17 mice. C) The total tumor weight per mouse was not quite significantly less in 
the CA/CO group than in the CO/CO group, p=0.15 by Mann-Whitney test. CO/CO n=14 mice; 
CA/CO n=17 mice. 
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Incidence 
At 110 days of age, no mice had tumors. The tumor incidence (whether or not a mouse has a 
tumor) at 130 days of age is shown in Figure 2.2A. The tumor incidence of the CA/CO group, 
(4/17 or 23%) was not quite significantly less (p = 0.1) by Fisher’s exact test than the tumor 
incidence of the CO/CO group, (7/14 or 50%). At 150 and 170 days of age, all mice had at least 
one tumor. Thus, the tumor incidence was 100%. 
 
Multiplicity  
Since these mice all bear a tumor promoting transgene, all mice are expected to develop tumors 
at some point. As shown in Figure 2.2B, the tumor multiplicity (number of tumors per mouse) at 
130 days of age was significantly less (p<0.001 by Mann-Whitney) in the CA/CO group than in 
the CO/CO group. Even at 170 days of age, Figure 2.3A, the multiplicity of tumors in the 
CA/CO group was slightly less than in the CO/CO group. 
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Fig. 2.3 Tumor multiplicity at 170 days and growth rate. A) The mean number of tumors per mouse at 
170 days was less, but not significantly different, in the CA/CO group (n=11) than in the CO/CO group 
(n=9). B) The tumor weight per mouse at 170 days was significantly less in the CA/CO group (n=11) than 
in the CO/CO group (n=9), p<0.02 by Mann-Whitney. C) The mean tumor growth rate in the CA/CO 
group from detection until 170 days of age was ½ the growth rate of the CO/CO group. 
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Total tumor weight 
The total tumor weight per mouse, calculated from autopsy data, indicates a difference in tumor 
burden due to the diet of the mother during gestation and lactation of the offspring. At 130 days 
of age, Figure 2.2C, the tumor weight in the CA/CO group was not quite significantly less (p = 
0.15 by Mann-Whitney) than that of the CO/CO group. By 170 days of age, Figure 2.3B, the 
tumor weight per mouse (due to both fewer tumors/mouse and slower growth of tumors that 
developed) in the CA/CO group was significantly less (p = 0.02 by Mann-Whitney) than that of 
the CO/CO group. 
 
Tumor growth rate 
The mean tumor growth rates, calculated from measured tumor growth of 11 tumors for the 
CO/CO group and 8 tumors for the CA/CO group, are shown in Figure 2.3C. Linear regression 
analyses were used to determine the growth rate of each tumor (data not shown). A T-test of the 
tumor growth rates showed that the mean tumor growth rates were slower in the CA/CO group 
but not quite significantly different, p=0.11.  
 
Number of glands with tumor 
The number of glands with tumor at each time point is illustrated in Figure 2.4. Two-way 
analysis of variance revealed that there were significant effects due to both diet and time. The 
number of glands with tumor was significantly less in the CA/CO group than in the CO/CO 
group, p=0.02, and as expected, the number of glands with tumor was significantly increased 
with time, p<0.0001. 
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Fig. 2.4 Glands with tumor per mouse with time. Two way analyses of variance showed that 
the number of glands with tumor per mouse with time was significantly different due to 
treatment (p=0.02) and to time (p=0.0001). Consumption of the canola oil containing diet by the 
mothers of these mice significantly decreased the number of glands with tumor. As expected, 
with time the number of glands with tumor increased in both groups. Number of mice per group 
at 110, 130, 150 and 170 days of age are: CO/CO - 14, 14, 5, 9, and CA/CO – 6, 17, 7, 11 
respectively. 
 
Taken together, these data indicate that maternal consumption of canola oil delayed appearance 
of tumors in these transgenic mice and slowed the growth rate of the tumors that arose, resulting 
in significantly reduced tumor burden at 170 days of age. 
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Table 2.3 Gene expression in mammary glands at 130 days of age. 
 Gene name 
Symbol 
Fold change 
CA/CO vs 
CO/CO 
Bcl2-associated X protein Bax 22.71 
B-cell leukemia/lymphoma 2 Bcl2 4.01 
Bcl2-like 1 Bcl2l1 -9.92 
Baculoviral IAP repeat-containing 3 Birc3 -2.35 
Breast cancer 1 Brca1 -2.35 
Chemokine (C-C motif) ligand 2 Ccl2 -2.25 
Cyclin-dependent kinase inhibitor 2A Cdkn2a 6.36 
CCAAT/enhancer binding protein (C/EBP), beta Cebpb 550.65 
Chemokine (C-X-C motif) ligand 9 Cxcl9 2.02 
Early growth response 1 Egr1 13.13 
Etoposide induced 2.4 mRNA Ei24 -2.15 
Engrailed 1 En1 3.48 
Fatty acid synthase Fasn -7.09 
Fibronectin 1 Fn1 -4.42 
Hedgehog-interacting protein Hhip -2.58 
Hexokinase 2 Hk2 4.63 
Homeo box A1 Hoxa1 -2.07 
Intercellular adhesion molecule Icam1 -2.05 
Insulin-like growth factor binding protein 3 Igfbp3 -2.51 
Inhibitor of kappaB kinase beta Ikbkb -3.13 
Interleukin 1 alpha Il1a -2.06 
Interleukin 2 receptor, alpha chain Il2ra -3.33 
Interleukin 4 receptor, alpha Il4ra -2.19 
Lymphoid enhancer binding factor 1 Lef1 -3.02 
Lymphotoxin A Lta -3.19 
Matrix metallopeptidase 10 Mmp10 2.87 
Matrix metallopeptidase 7 Mmp7 2.97 
Ngfi-A binding protein 2 Nab2 -4.71 
Nitric oxide synthase 2, inducible, macrophage Nos2 -3.31 
Patched homolog 1 Ptch1 -3.32 
Transcription factor 7, T-cell specific Tcf7 2.53 
Telomerase reverse transcriptase Tert -2.55 
Transferrin receptor Tfrc -2.04 
Transmembrane, prostate androgen induced RNA Tmepai -2.52 
Tumor necrosis factor Tnf -5.27 
Transformation related protein 53 Trp53 -2.74 
Vascular cell adhesion molecule 1 Vcam1 -3.16 
Wingless-related MMTV integration site 2 Wnt2 -2.24 
Mice were exposed to maternal consumption of either corn or canola oil diets.  Real time, reverse 
transcriptase PCR was performed to determine mRNA abundance in mammary glands of experimental 
mice at 130 days of age. Genes with greater than 2 fold differences in mRNA abundance, of the genes 
analyzed (see methods), are shown. 
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Effect of maternal diet on gene and protein expression at 130 days of age.  
Analysis of expression of genes involved in multiple cell signaling pathways in mammary glands 
of mice at 130 days of age was used to identify potential mechanisms for how maternal 
consumption of canola oil might slow mammary gland tumorigenesis in C3(1)TAg/129 mice  
offspring. We chose this time point because, at 130 days of age, there were mammary glands 
without tumor in each group so that changes in gene expression due to the maternal diet but not 
those due to the presence of a tumor could be assessed. A priori, we did not know which signal 
transduction pathway(s) might be important for any alterations in tumor development. The 
Mouse Signal Transduction Pathway Finder™ reverse transcriptase, real time PCR (rtPCR) 
panel profiles the expression of 84 key genes representative of 18 different signal transduction 
pathways. The CO/CO group was the control group, the CA/CO group was the experimental 
group for analysis. The presence of the large T antigen protein in each mammary gland was 
confirmed by Western Blot (data not shown). 
Table 2.3 presents genes that were analyzed and found to be at least 2 fold different 
between the two groups at 130 days of age. Differences in gene expression between groups at 
130 days of age must be due to sustained gene expression changes induced by the maternal diet 
since: 1) both groups were weaned to the same diet 109 days previously and 2) there are only 
very small differences in fat composition in the mammary gland at 130 days of age and these 
differences do not support the notion that increased omega-3 PUFA in the CA/CO group is 
influencing gene expression. The possible significances of some of the changes in gene 
expression are presented in the discussion. 
The differences in mRNA should be reflected in changes in protein abundance. Figure 
2.5 illustrates the results of Western blot for two genes of interest, fatty acid synthase (Fas) and 
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CCAAT/ enhancer binding protein β (C/EBPβ). The mouse mammary gland contains a high 
percentage of adipocyte as well as the epithelial cells that form cancer, thus, the protein change 
was normalized by the size of the epithelial cell compartment in the specimen, using cytokeratin, 
and for protein loading using GAPDH. Compared to the CO/CO group, at 130 days of age, Fas 
protein was significantly less in the CA/CO group whereas C/EBPβ protein was increased in the 
CA/CO group.  
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Fig. 2.5  Results of protein analyses for fatty acid synthase (Fas) and CCAAT/enhancer 
binding protein (C/EBP), beta at 130 days of age. Western blot for fatty acid synthase showed 
that Fas protein was significantly less (p = 0.02 by T-test, n = 3/group) and that C/EBPβ was not 
quite significantly higher (p = 0.06 by T-Test, n=3/group) in mammary glands of CA/CO mice 
than in CO/CO mice at 130 days. Values shown are relative density and have been corrected for 
protein loading (GAPDH) and for cytokeratin (to correct for the epithelial compartment of the 
assayed sample).   
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Discussion 
 
The results of this study indicate that incorporation of canola oil in the maternal diet delayed the 
development of mammary gland cancer in this transgenic mouse model. The mice exposed to 
canola oil during gestation and lactation had significantly fewer tumors per mouse and the tumor 
incidence was ½ that of the control mice at 130 days of age. By 170 days of age the canola 
exposed mice had almost as many tumors as the control mice. However, because the growth rate 
of the tumors that developed in the canola oil exposed mice was about ½ that of the control mice 
and the appearance of tumors was delayed, the tumor burden (tumor weight) in the canola 
exposed mice at 170 days of age was significantly less than that of the control mice. If these 
results can be extrapolated to humans they are important for 2 reasons: 1) incorporation of canola 
oil in the diet is an easy dietary change for humans to make and 2) the maternal diet can have a 
life-long influence on development of breast cancer in the daughter. 
Epidemiologic studies can be interpreted to support the notion that the maternal diet can 
influence breast cancer risk in the daughter. When Chinese, Japanese or Filipino women migrate 
to the United States, breast cancer rates rise over two generations to approach that of US women 
(Ziegler et al., 1993). Breast cancer incidence in first generation migrants (who consumed a 
Western diet but whose mothers consumed the traditional diet) was increased almost 3 fold over 
that of the Asian-born mother but was still lower than that of the general Western population, 
indicating that there remained some protection from breast cancer due to the mother’s traditional 
diet. In second generation migrants, whose mothers consumed a Western diet during gestation 
and lactation of the daughter, breast cancer risk was 5-fold higher than the breast cancer risk for 
the Asian born grandmother (Kolonel et al., 1980) and was the same as the general Western 
population. 
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What could explain the benefit of exposure to maternal consumption of the omega 3 fatty 
acids in canola oil? The fatty acid composition of the mammary glands was different between the 
two groups at 21 days of age, but by 130 days of age there were no real differences in fatty acid 
composition. However, at 130 days of age, there were significant differences in gene expression 
in the mammary glands of these mice. The PCR array that we chose assays mRNA abundance in 
84 key genes representative of 18 different signal transduction pathways that are important to the 
development of cancer. We found that there were multiple differences in gene expression 
between the 2 groups of mice when the mice were 130 days of age, 109 days after the last 
exposure to the diet that contained canola oil.  
Among the differential changes that were of special interest was the large increase in 
CEBPβ (CCAAT/ enhancer binding protein β) mRNA. Western blot confirmed that the mRNA 
was being translated to protein and that the quantity of protein was higher in the CA/CO group. 
CEBPβ  is a leucine zipper transcription factor. The expression of CEBPβ in the liver has been 
shown to respond to dietary changes (Chapin et al., 1994). Homodimers and heterodimers of 
CEBPβ initiate transcription of multiple factors involved in proliferation, differentiation and 
apoptosis in the mammary gland (Grimm and Rosen, 2003). Multiple isoforms of the protein, 
(including some that are dominant negatives) may be generated by truncation or proteolysis of 
the CEBPβ transcript (Zahnow, 2002). Slowed proliferation and increased differentiation could 
result in reduced tumor incidence while promotion of apoptosis could slow tumor growth. These 
mechanisms are supported by the phenotypic data however the exact meaning of increased 
CEBPβ expression in the mammary gland in this model will require additional study.  
The 7 to 8 fold decrease of fatty acid synthase mRNA and significant decrease in fatty 
acid synthase protein by maternal consumption of the canola oil diet is particularly interesting. 
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Increased expression of fatty acid synthase has been associated with the early steps of human 
mammary carcinogenesis (Esslimani-Sahla et al., 2007). Conversely, inhibition of fatty acid 
synthase has been associated with apoptosis of human breast cancer cells (Bandyopadhyay et al., 
2006) and has been suggested as a target for chemoprevention of breast cancer (Lu and Archer, 
2005). In cell culture studies, α-linolenic acid (increased in the canola oil diet) has been shown to 
be tumoricidal to breast cancer cells and to inhibit the overexpression of fatty acid synthase 
(Menendez et al., 2004). The long term suppression of fatty acid synthase would contribute to 
reduced tumor burden seen in this model. 
Another gene expression change that could reduce tumor burden was the 13-fold 
increased expression of Egr1 mRNA in the CA/CO group. Egr1 is a tumor suppressor gene that 
has been associated with suppression of proliferation (Singletary and Ellington, 2006). The 
expression of this gene has been shown to be increased by genistein and by retinoids (Singletary 
and Ellington, 2006; Liu et al., 2005) providing precedent for the regulation of this gene by 
dietary components. 
Even though we did not directly assess NFκB activation, the mRNA results suggest that 
activation of the transcription factor NFκB was reduced in mammary glands of pups from 
mothers that consumed the canola oil diet. The mRNA for inhibitor of κB kinase β (IKKβ) was 
reduced 3-fold in CA/CO pups at 130 days of age. Activation of IKKβ results in the 
phosphorylation of IκB (inhibitor of κB) and allows formation of NFκB dimers that can 
translocate to the nucleus and activate transcription of downstream genes (Hayden and Ghosh, 
2004). Activation of IKKβ is an important regulatory step in NFκB activity (Hayden and Ghosh, 
2004). Thus, reduced IKKβ would be expected to result in decreased activation of NFκB and 
reduction in mRNA of genes that are transcribed following NFκB binding. Genes downstream 
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from NFκB include inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF) and 
vascular cell adhesion molecule 1 (Vcam1). The mRNA from each of these genes was decreased 
2-to 5-fold, supporting the idea that NFκB activation was reduced in the CA/CO pups. Clearly 
there is much work to be done to verify this notion and to identify mechanisms. 
The mRNA changes in the Bcl-2 apoptotic pathway were also intriguing. Progression to 
apoptosis is a balance between pro-apoptotic genes such as Bcl-2 associated X (BAX) and anti-
apoptotic genes such as Bcl-2 and Bcl-2-like-1(Letai, 2008). At 130 days of age, the mammary 
glands of CA/CO mice had BAX mRNA at 22-fold and BCL-2-like 1 at 10-fold that of the 
CO/CO mice. Bcl2 was increased 4 fold but clearly the overall balance is to promotion of 
apoptosis of defective epithelial cells in the CA/CO mammary glands. 
 
 
 
Conclusions 
 
Clearly, consumption of canola oil by mothers of the experimental mice delayed mammary gland 
tumor development in this model. Our gene expression data have provided clues to mechanisms 
employed but identifying and verifying the mechanism(s) remains to be done. Because long term 
changes in the expression of multiple proteins, such as seen in this study, are often related to 
epigenetic modification of the promoter region of genes, we have initiated epigenetic studies to 
identify these changes. Future work includes verification of protein changes and developing 
reasonable pathways for the delay in cancer development seen in this model.  
It has been suggested that 30% or more of cancers could be prevented by dietary changes (World 
Cancer Research, 2007). Substituting canola oil for corn oil would increase the ratio of omega 3 
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fatty acids in the diet and is an easy, cost effective dietary change for people to make. Many 
animal studies have shown that increasing omega 3 fatty acids in the adult diet provides multiple 
benefits against cancer. This work suggests that substituting canola oil for the corn oil in the 
maternal diet may decrease risk for breast cancer in the daughter in addition to providing benefit 
for the mother.  
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Diets are consumed as whole foods, and the multiple components in foods could work 
synergistically and independently to reduce the risk for cancer. Walnuts contain ingredients that 
may slow cancer growth including omega 3 fatty acids in the form of alpha linolenic acids, 
phytosterols and antioxidants. In the previous study, we investigated the maternal consumption 
of a diet that differs only in omega-3 to omega-6 ratio compared to the control diet, on the risk 
for breast cancer in female offspring. We found that substituting canola oil for corn oil to 
increase omega-3 and reduce omega-6 fatty acids in the maternal diet suppressed mammary 
gland tumorigenesis in the offspring. In the next chapter, we investigated the regular 
consumption of walnut and its influence on breast cancer risk. The regular consumption of 
walnut in a population means that offspring in such a population are exposed to the nutrients 
from walnut during gestation, lactation and at adulthood. These offspring as well as individuals 
who consume walnut after weaning as would occur when children move to a different 
environment or choose to make walnut part of the diet, and individuals exposed to walnut via 
gestation and lactation alone were compared with individuals not exposed to walnut to assess for 
the risk of breast cancer.  
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Abstract 
Walnuts contain multiple ingredients that, individually, have been shown to slow cancer growth 
including omega-3 fatty acids, antioxidants and phytosterols. In previous research, consumption 
of walnuts has slowed the growth of implanted breast cancers. We wanted to determine whether 
regular walnut consumption might reduce the risk for developing cancer. Homozygous, male 
C(3)1 TAg mice were bred with female SV129 mice consuming either the control AIN-76 diet or 
the walnut containing diet. At weaning, the female hemizygous pups were randomized to control 
or walnut containing diets and followed for tumor development.  
Compared to a diet without walnut, consumption of walnut significantly reduced tumor: 
incidence (fraction of mice with at least one tumor), multiplicity (number of glands with 
tumor/mouse) and size. Gene expression analyses indicated that consumption of the walnut diet 
altered expression of multiple genes associated with proliferation and differentiation of 
mammary epithelial cells. A comparison with another dietary intervention indicated that the 
omega-3 content alone did not account for the extent of tumor suppression due to the walnut. 
The results of this study indicate that walnut consumption could contribute to a healthy diet to 
reduce risk for breast cancer. 
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Introduction 
Many scientists now think that diet can alter carcinogenesis (World Cancer Research fund, 
2007). Epidemiology studies have tried to identify individual components of whole foods that 
might reduce risk for cancer. However, these studies often indicate little or no benefit of 
consuming a specific dietary component. Clinical trials that have used specific supplements [i.e., 
calcium (Gregoire et al., 1989), calcium and wheat bran (Alberts et al., 1997), selenium and 
Vitamin E (Lippman et al., 2009)] often demonstrate little or no effect of the supplement. 
However, people consume whole foods; the multiple ingredients in individual foods as well as 
accumulated amounts of these components within a whole diet, could act additively or 
synergistically to contribute to reduction of risk for disease, including cancer. In support of this 
idea, one preclinical study reported that very low doses (more similar to dietary doses) of 
selenium and docosahexaenoic acid in combination were more effective against cancer than 
either of these components individually at high doses (Narayanan et al., 2004). 
Walnuts contain multiple ingredients (Maguire et al., 2004) that individually have been 
reported to reduce cancer risk or growth rate. These ingredients include: omega 3 fatty acids  
(Petrik et al., 2000; Berquin et al., 2008), phytosterols, especially β-sitosterol (Ju et al., 2004; 
Choi et al., 2003) and antioxidants (Han et al, 2006; Liu et al, 2009). We have previously 
reported that walnut in the diet of mice (human equivalent of two servings a day) would reduce 
the growth rate of implanted human breast cancers (Hardman and Ion, 2008). We have also 
reported that canola oil which contains α-linolenic acid, the 18C omega-3 fatty acid, 
incorporated in the maternal diet during gestation and lactation of offspring, significantly 
reduced mammary gland cancer risk in the offspring (Ion et al., 2010). Walnuts contain the 
highest fraction of α-linolenic acid of any tree nut (USDA, 2009). The current study was 
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designed to determine whether the risk for developing breast cancer might be reduced by regular 
walnut consumption, perhaps due to the high α-linolenic acid content.  
In designing mouse diets that were applicable to human consumption we used a 10% corn 
oil diet as the “control diet.” This diet has an omega-6 fatty acid (linoleic acid) content that is 
approximately equivalent to the linoleic acid content American diet. It turned out that the α-
linolenic acid content of the walnut diet was equivalent to the α-linolenic acid content of the 
canola oil diet, giving us the added value of comparing two interventions containing the same 
amount of α-linolenic acid to determine if the α-linolenic acid content of the walnut diet might 
be the primary cancer suppressive component of walnut. 
The C(3)1 TAg transgenic mouse is a well characterized breast cancer model and the 
females of these mice develop mammary gland cancer at a predicable rate (Green et al., 2000; 
Maroulakou et al., 2001). As in human tumors, the early stages are estrogen receptor α (ERα) 
positive, but the tumors become ERα-negative in later stages (Maroulakou et al., 2001). The 
cancer development is slow enough that a dietary modification can make a difference in tumor 
development. Use of this model allowed us to control the maternal diet as well as the diet of the 
experimental offspring. However, as with any dietary modification study, we cannot determine if 
subtraction of a detrimental component or addition of a beneficial component determined the 
difference in tumorigenesis. 
When a dietary component is routinely consumed within a population, the offspring are 
exposed to the component during gestation and lactation as well as by consumption after 
weaning. This notion is duplicated by the experiment reported here. Exposure to the walnut 
included in the maternal diet during gestation and lactation as well as by individual consumption 
after weaning provided significant protection from mammary gland cancer in the offspring. The 
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reduction in cancer risk cannot be explained solely by the omega-3 content of the diet. Increased 
consumption of walnut could be part of a healthy diet and reduce risk for cancer in future 
generations.  
 
Methods and Materials 
 
Animals  
 
Breeding pairs of mice bearing a transgene for the SV40 large T antigen with a C3(1) rat prostate 
steroid binding protein promoter were obtained from the Dr. Jeffrey Green. The female 
transgenic mice are expected to develop mammary gland cancer due to expression of the large T 
antigen in the mammary gland (Maroulakou et al., 2001). The transgenic line is maintained in the 
laboratory and all mice were genotyped to ensure presence of the transgene. Twenty, female 
SV129 mice, 6 weeks old were obtained from Charles River Laboratories (Wilmington, MA), 
quarantined for 2 weeks, and then moved to a study room. All animal work was approved by the 
Marshall University School of Medicine Institutional Animal Care and Use Committee.  
 
Study design 
SV129 females (breeder females) were split into 2 groups and numbered for identification. Ten 
female mice were placed on a diet containing 10% w/w corn oil (control diet, see below) and ten 
female mice were placed on a diet containing walnuts (test diet). The compositions of the diet 
and of the dietary fat are listed in Table 3.1. After 2 weeks these females were bred with 
homozygous C3(1)/TAg male mice. The hemizygous female pups from these breedings were the 
experimental mice NOT the wild type mother mice. Pups were weaned at 21 days old and were 
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randomized to the two diets, generating four experimental groups: corn oil/corn oil (CO/CO), 
corn oil/walnut (CO/walnut), walnut/walnut, or walnut/corn oil (walnut/CO) (the first diet was 
the maternal diet, the second diet was the pup’s diet). The offspring were housed 3 to 4 in a cage, 
individually numbered for identification, and weighed weekly.  
 
Diet  
Diets were prepared in the Marshall University School of Medicine animal diet prep room. Diet 
composition is shown in Table 3.1 and was formulated to be isocaloric, isonutrient and more 
relevant to human consumption than the very high fat diets used in many studies. (If a Western 
diet contains about 14.7g of linoleic acid/day (Johnson et al., 2007) the calories from linoleic 
acid are 6.6% of a 2000 calorie diet. The 10% corn oil mouse diet contained 10.9% of calories 
from linoleic acid. The walnut-containing diet was formulated to contain 18% of calories from 
walnut. This approximates a human diet that includes 2 servings (2 ounces) of walnut per day. 
(Two ounces of walnut, 28 halves, equals 370 calories; 370 calories = 18.5% of a 2000 calorie 
diet). The AIN-76A diet is adequate for the nutritional support of the mice (American Institute of 
Nutrition, 1977). The dry ingredients of the diet, except sugar, were obtained in bulk from MP 
Biomedicals (Solon, Ohio), sugar and corn oil were purchased locally (100% corn oil, no 
additives or preservatives). Walnuts were provided by the California Walnut Commission and 
kept frozen at -200C until used. Walnuts (with brown pellicle but without shells) were ground 
fine in a blender for mixing into the diet. Batches of diet were prepared as needed, about each 
two weeks. The diet mixture was pressed into trays and cut into small squares. Individual cage 
sized portions (25-30 g) were stored in sealed containers at -200C to prevent oxidation of the fat 
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and bacterial growth in the food. Mice had free access to food and water and were fed fresh food 
5 days per week. Food removed from cages was discarded. 
 
Transgene copy number  
Real time PCR was used to verify the presence of the transgene in all experimental pups, as 
previously described (Ion et al., 2010). Primers for the transgene (SV40 foward: ATA TGC 
CTT CAT CAG AGG AAT ATT C; SV40 reverse: TAA AGT TTT AAA CAG AGA GGA 
ATC TTT GC) and the VIC labeled SV40PROBE (VICCCC AGG CAC TCC TTT CAA GAC 
CTA GAA GGMGBNFQ), β-actin primers and PCR Master Mix were purchased from Applied 
Biosystems (Foster City, CA). The rtPCR assay was performed according to the Applied 
Biosystems instructions on an ABI Prism 7000 (Applied Biosystems, Foster City, CA) 
instrument. 
 
Body weights 
Body weights were measured each week and terminally. Statistical differences in mean body 
weight change between groups were determined using ANOVA and Prism© (Graphpad, Inc) 
software.   
Tumor incidence, multiplicity and weight 
Mice were palpated for tumors 3 times weekly from 90 days of age. Total tumor incidence, 
multiplicity and weights were determined at necropsy. The differences between groups and 
across time were statistically analyzed by Kruskal-Wallis, two way analyses of variance, Chi-
square, Fisher exact test or Mann-Whitney test as appropriate using Prism© software (Graphpad, 
Inc., La Jolla, CA). 
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Necropsy 
Mice were euthanized at 110, 130, 145 days of age. The earliest time for tumors was expected to 
be 110 days of age. Mice were euthanized thereafter to follow the increase in tumor incidence 
and multiplicity. The left 4th mammary gland was quickly removed and frozen in liquid nitrogen. 
All ten mammary glands were examined for the presence of a tumor 1mm or larger. All tumors 
detected were measured, removed and weighed, thus total tumor weight and numbers includes 
tumors that were too small to be detected by palpation. If a tumor was large enough for further 
assay, it was flash frozen in liquid nitrogen. The number of tumors in each gland and the number 
of glands with tumor were recorded for every mouse. Some mice in the CO/CO group had to be 
euthanized (due to large tumor size) before a scheduled 145 days thus slightly skewing (to a 
smaller size) the results for tumor mass in this group. 
 
Gas chromatography  
The fatty acid compositions of mammary glands at 130 days of age were analyzed by gas 
chromatography. Frozen tissues were thawed and homogenized in distilled water containing 
0.1% BHT to prevent oxidation of the fatty acids. Lipids were extracted with 
chloroform/methanol, the fatty acids were methylated followed by separation and identification 
using gas chromatography, as previously described (Witte et al., 2010). ANOVA followed by a 
Bonferroni posttest was used to determine statistical differences of individual fatty acids between 
dietary groups.  
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Gene expression assay  
The Mouse Signal Transduction Pathway Finder™ RT² Profiler™ PCR Array, PAMM-014 
(SuperArray Bioscience Corporation, Frederick, MD) was used to analyze the expression of 84 
genes in 3-4 mammary glands per group at 130 days of age mice.  (The complete list of genes on 
the plate can be found at: www.sabiosciences.com/rt_pcr_product/HTML/PAMM-014A.html.) 
The Signal Transduction pathway finder array was used because, a priori, we did not know what 
genes or pathways might be influenced by consumption of the walnut diet. Mammary gland 
without macroscopic tumor was analyzed to obtain changes due to the diet not to the presence of 
a tumor. This array profiles genes in 18 different pathways that could be applicable to cancer 
development. Frozen tissue was homogenized in Tri Reagent (Sigma-Aldrich, St. Louis, Mo) 
following the protocol of the manufacturer to isolate the RNA. RNA quality control was 
performed for all samples to insure the purity and integrity of the RNA on an Agilent 2100 
Bioanalyzer (Santa Clara, CA). The RT2 First Strand Kit was used to make cDNA; the cDNA 
was then quantitatively amplified by real time PCR using an ABI Prism 7000 (Applied 
Biosystems, Foster City, CA) and RT2 qPCR Master Mix (Superarray) according to the 
manufacturer’s protocol. The protocol and software provided by SuperArray were followed to 
determine relative fold difference in gene expression using the ∆∆ct method and for statistical 
analyses of the data by T-test. 
 
Immunoblot analysis  
Tri Reagent (SIGMA, Missouri,USA) was used to homogenize and isolate protein from frozen 
mammary gland tissues following the manufacturer’s protocol. Protein concentration was 
determined by BCA protein Assay Kit (EMD Biosciences, Inc. Darmstadt, Germany) following 
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the manufacturer’s protocol. Ten micrograms of protein were applied to each lane of a 4-15% 
Tris-HCl polyacrylamide gradient gel (Bio-Rad, Hercules, CA), separated by electrophoresis and 
then transferred onto a nitrocellulose membrane. The blots were blocked with 5% BSA in TBST 
overnight at 4oC and probed with primary antibodies against: Nitric oxide synthase Type II (NOS 
2), Simian virus 40 Large T antigen (SV40 T Ag) (BD Biosciences); NF kappa B inhibitor alpha 
(IκB alpha) (Abcam Inc.); or inhibitor of NF kappa-B kinase beta (IKK beta) (Cell Signaling 
Technology, Inc.), in blocking buffer for 1hr at room temperature. Cytokeratin 8 (Santa Cruz 
Biotechnology, Inc.) was used to normalize for the epithelial compartment of the mammary 
gland specimen and GAPDH (CHEMICON International) was used to normalize protein loading. 
The membrane was thereafter incubated with horseradish peroxidase (HRP) conjugated 
antimouse (Santa Cruz Biotechnology, Inc.) or antirabbit (PIERCE, Inc.) secondary antibody. 
Band detection was done with chemiluminescence ECL Kit (PIERCE, Inc.). Densitometry was 
used to quantify the bands. A ChemDoc XRS system (Bio-Rad Laboratories Inc., Hercules, CA) 
was used to acquire the image then image analysis was done using ‘Quantity One’ software, V. 
4.5.2 (Bio-Rad Laboratories Inc., Hercules, CA). Tissue availability (many of walnut consuming 
mice either had no or very small tumors) limited the number of repeats that could be performed. 
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Results 
Body weight and weight gain 
There were no differences between groups in terminal body weight at any of the necropsy time 
points. Body weight gain between 91 and 135 days were (mean g ± SD): CO/CO = 3.85 ± 1.05; 
CO/walnut = 2.87 ± 1.5; walnut/walnut = 2.72 ± 1.1; walnut/CO = 2.12 ± 1.1. ANOVA indicated 
no significant differences between these weight gains. The groups with the greatest difference in 
tumor incidence and size were the CO/CO and Wal/Wal groups. However, there was no 
significant difference in body weight (mean ± SD of 12 mice/group: CO/CO=24.85 ± 1.6g vs 
Wal/Wal=24.25 ± 1.4g) at 135 days (before any tumor cachexia). The mean tumor mass of the 
CO/CO group was 1/3 of the variance in body weight thus it does not seem that the tumor mass 
was a significant portion of the mouse weight gain though certainly some of the extra weight 
gain in the CO/CO group could be due to tumor growth. An important point here is that free 
access to walnut, a high calorie food, in the diet did not increase weight gain as would be a 
concern of many readers. Clinical trials have also indicated that addition of walnut to the diet 
does not increase body weight or cause weight gain in people (Sabate, 2003; Sabate et al., 2005; 
Gillen et al., 2005).  
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Table 3.1 Compositions of the diets 
Fat composition (g/100g) of corn oil and walnut from (USDA, 2009). Small amounts of various lipids 
make up the remainder of the fat and are not listed. 
 
Fatty acid composition of the diet and of the mammary gland: 
Table 3.1 shows that the corn oil diet contained more oleic acid (monounsaturated fat) and 
saturated fat but that the walnut diet contained more linoleic acid and α-linolenic acid. The fat 
composition of the mammary gland (Figure 3.1) reflects the fat composition of the diet, that is, 
the mammary glands of mice that consumed the walnut diet after weaning contained 
 Corn oil 
(Control) 
diet 
Both diets Walnut diet 
(18% of calories from walnut) 
Diet compositions g/kg diet calories/g 
diet 
% of total 
energy 
g/kg diet Additional nutrient 
contained in 111 g 
walnut/kg diet 
Casein 200 0.80 19.2 183g Protein -17.2g 
Sucrose 450 1.800 43.4 450g  
Corn starch 150 0.60 14.46 135g Carbo – 15.5g 
Alphacel 50 0 0 48g Fiber – 2.0g 
Choline bitartrate 2.0 0 0 2g  
DL-methionine 3.0 0 0 3g  
AIN-76 Mineral mix 35.0 0.02 0.4 35g  
AIN-76A Vitamin mix 10.0 0.030 0.7 10g  
Ground walnut 0   111g  
Fat (10% total fat)  100g corn oil 0.90 21.7 26.3g corn 
oil 
Fat – 73.7g 
Totals 1000g 4.15cal/g 99.9 1003g (4.6g water in walnut) 
      
Fat in diet From Corn oil 
g/kg diet 
  From Corn 
oil 
g/kg diet 
From 
Walnut 
g/kg diet 
Total 
g/kg diet 
        Oleic acid 27.33   7.2 9.7 16.9 
        Linoleic acid 53.2   14.0 41.9 55.9 
      α-Lenolenic acid 1.2   0.3 10.0 10.3 
   Total saturated fat 12.9   3.3 6.7 10.0 
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significantly less oleic acid and significantly more linoleic acid, α-linolenic acid and total omega 
3 fats than did the mammary glands of the mice that consumed the corn oil diet after 
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Fig. 3.1 Gas chromatography for fatty acids in mammary gland. Gas chromatography was 
used to analyze fatty acids in the mammary gland. Shown are the monounsaturated (oleic) and 
polyunsaturated (omega-6 (n-6), linoleic and omega-3 (n-3), linolenic) fatty acids that were 
significantly different due to the diet. Total omega-6 includes linoleic acid (18C) and arachidonic 
acid (20C) and total omega-3 fatty acid includes α-linolenic acid (18C), eicosapentaenoic (20C), 
docosapentaenoic (22C) and docosahexaenoic (22C) acids. Individually, the fractions of the 20C 
and 22C fatty acids were not different between diets (by T-test). Fatty acid compositions reflect 
the current diet and are as expected based on the fat composition of the diet. (n=4-5 per group, 
p<0.05 by ANOVA) 
 
weaning [two-way ANOVA (fatty acid and diet group) followed by Bonferroni posttest, p<0.05]. 
There were no other fatty acids that were significantly different due to diet.  
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Tumor incidence and multiplicity 
At 110 days of age, the first euthanasia point, no mice had tumors. Figure 3.2 shows the tumor 
size, incidence and multiplicity at 130 and 145 days of age. At 130 days it appears that 
consumption of walnut is increasing the latency of tumors. However, largely due to the early 
stage of tumorigenesis, neither the tumor mass (Figure 3.2A, Kruskal Wallis, p-value for  
Walnut/Walnut vs Co/CO = 0.06) multiplicity (Figure 3.2B, number of glands with tumor, by 
ANOVA) nor the tumor incidence (Figure 3.2C, fraction of mice with any tumor, by Fisher’s 
exact test) were significantly different. 
By 145 days, suppression of tumorigenesis by the walnut containing diet was clearly 
evident. The median tumor size of the walnut/walnut group was significantly less than of the 
CO/CO group (Figure 3.2D, p<0.05, Kruskal-Wallis followed by Dunn’s multiple comparison 
test). (Some mice in the CO/CO group had to be euthanized due to large tumor size before the 
scheduled 145 days thus slightly skewing the results for tumor mass in this group to a smaller 
mass than if the mice had lived to 145 days old.). The multiplicity of tumor was decreased in 
both groups that consumed walnut after weaning with the multiplicity of tumor in the 
walnut/walnut group being significantly less (Figure 3.2E, p<0.05, Kruskal-Wallis followed by 
Dunn’s multiple comparison test) than in the group not exposed to walnut (CO/CO).  
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Fig. 3.2 Tumor mass, multiplicity and incidence at 130 and 145 days of age. Mammary gland 
tumors were quantified at euthanasia at 130 and 145 days of age, n = 10-13 mice per time point 
and diet group. By 145 days, the total tumor mass, number of glands with tumor (multiplicity) 
and tumor incidence of the walnut/walnut group was significantly less than of the corn oil/corn 
oil group. Consumption of walnut after weaning (corn oil/walnut group) also decreased the 
multiplicity, the mass and the incidence or tumors (groups which share a letter are not 
significantly different p<0.05, statistical test stated in Results). 
 
The tumor incidence was less in both groups that consumed walnut after weaning than in the 
group not exposed to walnut (Figure 3.2F, CO/CO) with the tumor incidence in the 
walnut/walnut group being significantly less than the tumor incidence of the CO/CO group 
(P<0.05 by Fisher’s exact test). Tumor incidence was decreased 40% compared to the CO/CO 
group when walnut was consumed after weaning, however, with 10 mice in a group this did not 
reach significance.  
 
PCR array analyses for mRNA expression followed by western blot 
The mRNA from a total of 84 genes was quantitatively assayed by the Mouse Signal 
Transduction Pathway Finder™ RT² Profiler™ PCR Array. Table 3.2 lists the 41 genes of these 
genes in which expression in the mammary gland was changed either more than 2 fold or with a 
P-value < 0.05 by T-test (using the manufacturer’s statistical analyses software). Genes in the 
arrays are listed in the applicable pathways at the bottom of Table 3.2, with genes that were 
significantly altered by walnut consumption shown in italics and green color. The expression of 
many genes in pathways associated with mitogenesis, survival or NFκB and other signaling has 
been altered by exposure to dietary walnut. 
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We noted that a number of the genes with altered expression are in the NFκB signaling 
pathway so three of these genes [NFκB inhibitor alpha (IkB, Nfκbia), ikB kinase (IKK, Ikbkb) 
and nitric oxide synthase 2 (iNOS or Nos2)] were chosen for Western blot analyses. Western blot 
results (Figure 3.3) were in general agreement with the PCR array analyses for these genes and 
with the actual tumor incidence results. That is, compared to protein abundance in the mammary 
glands of the CO/CO group, protein abundance of Nfκbia was increased and of Ikbkb was 
decreased in the walnut/walnut group. Because Nfκbia binds and prevents activation of NFκB 
and Ikbkb cleaves Nfκbia to allow activation of NFκB, these coordinated changes would be 
expected to decrease NFκB activation and to be associated with suppression of cancer risk 
(Aggarwal et al, 2004). Nfκbia was also increased in the CO/walnut and in walnut/CO groups 
but Ikbkb was not changed. These results would be expected to be associated with less tumor su 
ppression in the CO/walnut and walnut/CO groups than in the walnut/walnut group. Inducible 
nitric oxide synthase (Nos2) mRNA was slightly decreased but protein was barely detectable in 
any group and was not changed by a walnut containing diet. 
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Table 3.2 Gene expression altered by walnut diet 
Symbol 
*T-
TEST 
Fold 
difference   
*T-
TEST 
Fold 
difference   
*T-
TEST 
Fold 
difference 
  p value 
CO/walnut 
vs CO/CO   p value 
walnut/wal
nut vs 
CO/CO   p value 
walnut/CO 
vs CO/CO 
Activating transcription 
factor 2 - ATF2 0.004 2.597   0.034 1.737   0.021 1.838 
Bcl2-associated X protein - 
BAX 0.079 107.535   0.074 119.263   0.079 105.420 
B-cell leukemia/lymphoma 
2 - Bcl2 0.163 27.338   0.292 11.867   0.178 24.098 
Baculoviral IAP repeat-
containing 2 - Birc2 0.002 4.328   0.076 1.896   0.007 3.375 
Bone morphogenetic 
protein 2 - BMP2 0.109 17.182   0.095 19.865   0.139 12.914 
Bone morphogenetic 
protein 4 - BMP4 0.486 3.254   0.450 3.592   0.399 4.228 
Cyclin-dependent kinase 
inhibitor 2A - Cdkn2a 
(p16) 0.011 950.691   0.026 216.092   0.024 308.865 
CCAAT/enhancer binding 
protein (C/EBP), beta 0.014 2876.968   0.027 790.342   0.016 2152.305 
Chemokine (C-X-C motif) 
ligand 1 - Cxcl1 0.001 9.309   0.001 4.728   0.000 3.732 
Early growth response 1 - 
EGR1 0.033 472.608   0.037 363.002   0.057 168.410 
Engrailed 1 - En1 0.000 21.449   0.162 6.895   0.000 43.236 
Fas (TNF receptor 
superfamily member) 0.000 5.794   0.123 1.782   0.000 5.084 
Fatty acid synthase - Fasn 0.365 7.350   0.447 5.280   0.332 8.649 
FBJ osteosarcoma 
oncogene-  FOS 0.068 67.275   0.077 59.356   0.124 29.446 
Growth arrest and DNA-
damage-inducible 45 alpha 
- Gadd45a 0.067 3.519   0.083 3.156   0.166 2.362 
Gene regulated by estrogen 
in breast cancer protein - 
Greb1 0.280 -2.328   0.096 -4.923   0.150 -4.134 
Glycogen synthase 1, 
muscle - Gys1 0.002 -2.717   0.009 -2.213   0.000 -2.086 
Hedgehog-interacting 
protein - Hhip 0.035 2.111   0.164 -3.308   0.003 4.285 
Hexokinase 2 - Hk2 0.192 35.886   0.237 24.499   0.213 29.719 
Heat shock factor 1 - Hsf1 0.200 15.378   0.987 -1.034   0.221 13.462 
Insulin-like growth factor 
binding protein 4 - Igfbp4 0.241 18.214   0.205 24.584   0.229 19.904 
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Inhibitor of kappaB kinase 
beta - Ikbkb 0.305 -2.727   0.168 -6.874   0.236 -3.456 
Interleukin 2 - Il2 0.182 2.749   0.127 4.986   0.804 1.260 
Interleukin 2 receptor, 
alpha chain - Il2ra 0.091 -4.650   0.042 -12.622   0.103 -5.448 
Interleukin 4 receptor, 
alpha - Il4ra 0.025 -6.221   0.045 -8.601   0.029 -6.317 
Jun oncogene - Jun 0.000 506.529   0.336 2.230   0.000 465.456 
Transformed mouse 3T3 
cell double minute 2 - 
Mdm2 0.015 71.937   0.036 29.135   0.020 53.199 
Matrix metallopeptidase 10 
- Mmp10 0.077 2.350   0.167 3.487   0.541 1.275 
Matrix metallopeptidase 7 - 
Mmp7 0.206 2.285   0.004 10.664   0.044 3.647 
Myelocytomatosis 
oncogene - Myc 0.040 1.739   0.089 -4.569   0.223 1.360 
Ngfi-A binding protein 2 - 
Nab2 0.000 -7.938   0.215 -2.961   0.000 -8.042 
Nuclear factor of kappa 
light chain gene enhancer 
in B-cells inhibitor, alpha - 
Nfkbia 0.196 20.971   0.267 12.874   0.213 18.358 
Nitric oxide synthase 2, 
inducible, macrophage - 
Nos2 0.021 -3.080   0.015 -2.922   0.130 -1.813 
Patched homolog 1 - Ptch1 0.062 -4.102   0.004 -21.412   0.075 -3.651 
    
TRAF family member-
associated Nf-kappa B 
activator - Tank 0.018 4.188   0.351 -2.890   0.029 3.389 
Transcription factor 7, T-
cell specific - Tcf7 0.126 70.661   0.337 12.807   0.239 28.003 
Telomerase reverse 
transcriptase - Tert 0.120 -1.423   0.929 -1.042   0.127 -1.422 
Tmepai 0.076 -5.109   0.029 -147.067   0.029 -8.545 
Tumor necrosis factor - Tnf 0.847 -1.106   0.075 -3.123   0.454 -1.762 
Vascular cell adhesion 
molecule 1 - Vcam1 0.046 1.750   0.040 -2.019   0.510 1.193 
Vascular endothelial 
growth factor A - Vegfa 0.008 -2.094   0.086 -1.621   0.003 -2.612 
WNT1 inducible signaling 
pathway protein 1 - Wisp1 0.076 12.556   0.250 4.055   0.097 8.825 
*Available statistical software only allowed T-tests of test group verses a control group. 
Genes with significantly different expressions as determined by PCR array. All comparisons are to the 
corn oil/corn oil group. Genes with expression that differed by more than 2 fold or with a p<0.05 are 
listed. 
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Pathways associated with genes above. Italics and green color denote genes with altered 
message in above table. 
Mitogenic Pathway:  Egr1 (egr-1), Fos (c-fos), Jun (c-jun), Nab2. 
Wnt Pathway: Birc5, Ccnd1 (cyclin D1), Cdh1, Fgf4, Jun (c-jun), Lef1, Myc (c-myc), Pparg, Tcf7, Vegfa, Wisp1.  
Hedgehog Pathway: Bmp2, Bmp4, En1 (engrailed), Foxa2 (forkhead box A2 / HNF3B), Hhip, Ptch1 (patched 1), 
Wnt1, Wnt2.  
TGF-β Pathway: Cdkn1a (p21Waf1, p21Cip1), Cdkn1b (p27), Cdkn2a (p16Ink4), Cdkn2b (p15 Ink2b).  
Survival Pathway:  
PI3 Kinase / AKT Pathway:  Bcl2 (Bcl-2), Ccnd1, Fn1 (fibronectin), Jun (c-jun), Mmp7 (matrilysin), Myc (c-myc). 
Jak / Src Pathway:  Bcl2 (Bcl-2), Bcl2l1 (Bcl-XL). 
p53 Pathway: Bax, Cdkn1a (p21Waf1, p21Cip1), Ei24 (Pig3), Fas (Tnfrsf6), Gadd45a (gadd45), Igfbp3, Mdm2.  
Stress Pathway: Atf2, Fos (c-fos), Hsf1 (tcf5), Hspb1 (Hsp25), Myc (c-myc), Trp53 (p53).  
NFκB Pathway: Birc1a, Birc2 (c-IAP2), Birc3 (c-IAP1), Ccl20, Cxcl1, Icam1, Ikbkb, Il1a, Il2, Lta (TNFb), Nfkbia, 
Nos2 (iNOS), Tank, Tnf (TNFa),Tert, Vcam1.  
NFAT Pathway: Cd5, Fasl (Tnfsf6), Il2.  
CREB Pathway:  Cyp19a1, Egr1 (egr-1), Fos (c-fos).  
Jak-Stat Pathway:  Cxcl9 (MIG), Il4ra, Irf1, Mmp10 (stromelysin-2), Nos2 (iNOS).  
Estrogen Pathway:  Bcl2 (Bcl-2), Brca1, Greb1, Igfbp4, Nrip1.  
Androgen Pathway:   Cdk2, Cdkn1a (p21Waf1, p21Cip1), Tmepai.  
Calcium and Protein Kinase C Pathway: Csf2 (GM-CSF), Fos (c-fos), Il2, Il2ra (IL-2 R?), Jun (c-jun), Myc (c-
myc), Odc1, Tfrc.  
Phospholipase C Pathway: Bcl2 (Bcl-2), Egr1, Fos (c-fos), Icam1, Jun (c-jun), Nos2 (iNOS), Ptgs2 (cox-2), 
Vcam1.  
Insulin Pathway: Cebpb (C/EBP-β), Fasn (fatty acid synthase), Gys1 (GS, glycogen synthase), Hk2 (hexokinase II), 
Lep (Ob).  
LDL Pathway: Ccl2, Csf2 (GM-CSF), Sele, Selp (P-selectin), Vcam1.  
Retinoic Acid Pathway: En1 (engrailed), Hoxa1, Rbp1 (CRBPI).  
The data indicate that walnut consumption influences pathways involved in cell proliferation, cell death 
and differentiation of the mammary glands and that would be expected to alter carcinogenesis. 
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Fig. 3.3 Protein quantification for genes of interest in NFκB pathway. Increased NFκB activity 
has been associated with increased carcinogenesis. Western blot followed by densitometry was used 
to quantify NFκB inhibitor alpha (Nfκbia), inhibitor of kappa B kinase beta (Ikbkb) and inducible 
nitric oxide sythase. Nfκbia binds to and keeps NFκB inactive, Ikbkb cleaves Nfκbia for activation of 
NFκB thus increased Nfκbia and decreased Ikbkb would be associated with less activation of NFκB. 
Nos2 is downstream of NFκB but protein was not changed. N=3 mice per group. Individual protein 
changes are not significantly different. GAPDH bands are shown. Because we were interested in 
gene expression in the epithelial cells, columns in graphs show protein normalized for cytokeratin 
which is present in epithelial cells of the mammary gland.  
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Comparison of tumor multiplicity with a diet containing the same omega 3 amount as the 
walnut diet 
We have previously reported partial results of a study in which incorporation of canola 
oil instead of corn oil was the dietary intervention (Ion et al., 2010). The experimental design 
was the same as above except that 10% canola oil was incorporated into the diet of some mother 
mice and offspring instead of 10% corn oil. The canola oil diet contained 1% α-linolenic acid 
(10g/kg dry weight), the same amount of α-linolenic acid as in the walnut diet of this study. The 
canola  
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Fig. 3.4 Glands with tumor per mouse for corn oil/corn oil (CO/CO), canola oil/canola oil 
(CA/CA) and walnut/walnut groups. This experimental design represents dietary exposures for 
a population that routinely consumes these components in the diet. Tumor multiplicity for each 
group is significantly different (p<0.05, two-way ANOVA, Bonferroni post test) from the two 
other groups, CO/CO>CA/CA>walnut/walnut as indicated by different letters for each data set. 
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oil study (with different funding) was run in parallel and at the same time as the walnut study 
using the same control group. Figure 3.4 shows the number of glands with tumor per mouse with 
time, from 110 to 145 days of age. It is clear that fastest tumor development was when the diets 
of mother and offspring contained only corn oil (CO/CO), providing canola oil in the diet 
significantly suppressed tumor development (CA/CA), yet there was additional significant 
suppression of tumor development when walnut was included in the diet (Walnut/Walnut). The 
number of glands with tumor per mouse of each group are each significantly different from the 
other two groups (two way ANOVA followed by Bonferroni post-test, n=11-13 mice per time 
point). 
 
 
Discussion 
Epidemiology studies indicate that some populations have lower incidences of cancer (World 
Cancer Research Fund, 2007; Mitrou et al., 2007), the challenge is to identify the foods that 
contribute to reducing cancer risk given the complex compositions of whole foods. Another 
challenge in all dietary studies is to determine whether it is the addition of a beneficial 
component or the subtraction of a detrimental component that provided the benefit against 
cancer.  
The primary aim of this study was to assess the effects of walnut consumption on 
mammary gland cancer risk. The results presented herein indicate that walnut consumption could 
significantly alter expression of multiple genes and mammary gland cancer development. Walnut 
consumption by both mother and offspring, as would naturally occur when walnuts are 
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consumed as part of the usual diet of a population, did significantly reduce mammary gland 
cancer development and reduced multiplicity in this transgenic mouse. Consumption of walnut 
after weaning, as might occur when children migrate to a different environment or choose to add 
walnut to their diet, also slowed mammary gland cancer development; showing a 40% reduction 
in tumor incidence and a 44% reduction in multiplicity compared to mice not exposed to walnut. 
The next question is: What component of walnut was effective at slowing carcinogenesis? 
Our first hypothesis was that the increased omega-3 content and decreased omega-6 
content of the diet reduced carcinogenesis. Long chain omega-3 fatty acids have been shown to 
slow breast cancer growth in multiple animal studies (examples Karmali et al., 1984; Karmali et 
al., 1987; Rose and Connolly, 1993; Cave, 1997;  Rose and Connolly, 1999; Petrik et al., 2000) 
and have been proposed for cancer prevention (Rose and Connolly, 1999). Conversely, omega-6 
fatty acids, especially linoleic acid as found in corn oil, have been shown to increase 
carcinogenesis (Rose et al., 1994; Hilakivi-Clarke et al., 1997; Rose et al., 1999). In order to 
maintain balanced fat in the diet, if one species is increased (α-linolenic) then another (linoleic) 
has to decrease. We had data from another recently completed study [partially reported (Ion et 
al., 2010)] which provided information that indicated that increasing the α-linolenic content 
contributed to reduced mammary gland cancer risk. After doing the calculations we realized that 
the canola oil and walnut diets contained the same amount of omega-3 in the form of α-linolenic 
acid. The canola oil containing diet did significantly suppress tumorigenesis compared to the 
corn oil containing diet. However, the walnut diet resulted in an additional significant 
suppression of tumorigenesis. Thus, some component of the diet, in addition to the increased α-
linolenic content (or reduced linoleic acid), was functioning to suppress carcinogenesis.  
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There are reports that β-sitosterol can suppress cancer cell growth (Moon et al., 2007; 
Moon et al., 2008; Zhao et al., 2009) and walnuts contain a significant amount of β-sitosterol 
(Maguire et al., 2004; Pereira et al., 2008). However, in assessing the β-sitosterol composition of 
the diets [using composition of the diet and (USDA, 2009)] we found that the β-sitosterol content 
was : corn oil diet - 968 mg/kg; canola oil diet – 413 mg/kg; walnut diet – 71 mg/kg thus the 
total β-sitosterol content of the walnut diet was less than that of the corn oil diet. Most of the 
references for benefit of β-sitosterol against cancer do NOT use breast cancer cells, which might 
be stimulated by binding of β-sitosterol to the estrogen receptor, but use other cell types that are 
not usually considered estrogen dependent. Interestingly, we did find one paper (Ju et al., 2004) 
indicating that β-sitosterol may increase breast cancer cell growth in estrogen responsive cells; 
this would agree with our data. The tumors formed by this C3(1)/SV40 TAg model have been 
well characterized (Green et al., 2000; Maroulakou et al., 2001). Green et al., (2000) report that: 
“atypia of the mammary ductal epithelium develops at about 8 weeks of age, progressing to 
mammary intraepithelial neoplasia (resembling human ductal carcinoma in situ) at about 12 
weeks of age with invasive carcinomas at about 16 weeks in 100% of female mice. The tumors 
appear hormone responsive at early stages, invasive carcinomas are hormone independent, which 
corresponds to loss of ERα during progression.” Tumors were evident sooner in the mice that 
consumed the corn oil diet, perhaps in response to the β-sitosterol stimulation of ERα. At later 
times, when tumors became invasive and should be ERα-, the growth of tumors of mice that 
consumed the corn oil diet was not as influenced by corn oil diet. More research will be needed 
to determine the role of β-sitosterol in mammary carcinogenesis. 
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Assessment of vitamin E in the diets did provide a lead to an additional active component 
that was common to the diets. We found the gamma tocopherol is associated with slowing cancer 
cell growth (Yu et al., 2009; Lu et al., 2010; Pierpaoli et al., 2010) whereas alpha tocopherol did 
not have benefit against cancer and may block some of the activity of gamma tocopherol. 
Assessing the tocopherol content of the diets revealed: corn oil diet – alpha tocopherol -14.3 
mg/kg, gamma tocopherol – 0; canola oil diet – alpha tocopherol -17.46 mg/kg diet, gamma 
tocopherol – 27.34 mg/kg diet; walnut – alpha tocopherol 1.77 mg/kg diet, gamma tocopherol – 
22.9 mg/kg diet. The changes of alpha and gamma tocopherol are clearly in the direction that 
according to the work of others would indicate benefit against cancer. Studies could be devised 
to test this question. 
 
 
Conclusion 
These data indicate that exposure to a small amount of walnut in the diet of this transgenic 
mouse slowed the development and reduced the multiplicity of mammary gland cancers but does 
not define the mechanism of action for the walnut nor an “active ingredient” of the walnut. 
Walnut in the diet was associated with alterations in cell signaling pathways involved in 
proliferation, cell differentiation, and apoptosis. The signaling pathways altered in mammary 
glands of these mice have been identified as important in the development of human breast 
cancer thus this study should be relevant to humans. The fatty acid composition of the mammary 
glands was altered but comparison to another study with the same amount of omega-3 fatty acids 
in the diet indicates that increased omega-3 fatty acids in the mammary gland alone does not 
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explain the altered tumor incidence. However, alterations in dietary gamma tocopherol were 
inversely associated with tumorigenesis.  
More work will need to be done to determine the components of walnut and the 
mechanisms associated with tumor suppression. However, humans eat the whole nut, not specific 
components. It seems likely that incorporation of walnuts as part of a healthy diet could reduce 
the risk for breast cancer in humans.  
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In the previous two chapters, we investigated the maternal consumption of canola oil diet on 
breast cancer risk in the offspring, and the regular consumption of walnut diet on the risk for 
breast cancer. Mammary gland tumorigenesis was suppressed due to consumption of canola oil 
or walnut diet. Studies have reported that diet also plays a role in the development of prostate 
cancer. The next chapter presents my investigation on the effects of the consumption of high 
omega-3 fatty acid diet from fish oil concentrate on prostate tumorigenesis. Fish oil is a good 
source of longer chain omega-3 fatty acids namely, EPA and DHA. 
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Abstract 
Prostate cancer incidence and mortality are high in the Western world and high omega-6/omega-
3 PUFA ratio in the Western diet may be a contributing factor. We investigated whether 
changing from a diet that approximates the omega-6 fat content of the Western diet to a high 
omega-3 fat diet at adulthood might reduce prostate cancer risk. 
Female SV129 mice that had consumed a high omega-6 diet containing corn oil for 2wks 
were bred with homozygous C3(1)TAg transgenic male mice. All male offspring were weaned to 
the corn oil diet until post puberty when half of the male offspring were transferred to a high 
omega-3 diet containing canola oil and fish oil concentrate. 
High omega-3 diet increased omega-3 and decreased omega-6 fat content of mice tissues. 
The average weights of prostate and genitourinary bloc were significantly lower in mice 
consuming high omega-3 diet at adulthood (CO-FS) than mice fed a life-time high omega-6 diet 
(CO-CO). There was slower progression of tumorigenesis in dorsolateral prostate of CO-FS than 
in CO-CO mice. CO-FS mice had lower plasma testosterone level at 24wks and 40wks, 
significantly lower estradiol level at 40wks, and significantly less expressed androgen receptor in 
the dorsolateral prostate at 40wks than CO-CO mice. Consumption of high omega-3 diet 
decreased the expression of genes expected to increase proliferation and decrease apoptosis in 
the dorsolateral prostate. 
Our results suggest that consumption of high omega-3fatty acid diet slows down prostate 
tumorigenesis by promoting apoptosis and suppressing cell proliferation, in association with 
lowering estradiol, testosterone, and androgen receptor levels in C3(1)Tag mice. 
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Introduction 
Prostate cancer has remained the most frequently diagnosed cancer and the second leading cause 
of cancer related death among men in the US, accounting for 28% of total expected cancer 
incidence in men of US in 2010 (Jemal et al., 2010). In general, the incidence and mortality of 
prostate cancer are high in North America and Northern Europe, but much lower in Japan and 
other Asian countries (Jemal et al., 2011). Migration studies show that Asian men living in the 
US have a lower risk of prostate cancer than the Caucasians, but have a higher risk than their 
counterparts living in Asia (Platz and Giovannucci, 2006). Japanese men that immigrate to the 
US die of prostate cancer with increasing frequency as a function of the number of years of their 
residency (Astorg, 2004). The major factor for this increased frequency in prostate cancer death 
is thought to be the Western diet. 
Polyunsaturated fatty acids (PUFA) are a component of dietary fat reported from several 
investigations to influence the development of prostate cancer (Rose and Connolly, 1991; 
Pandalai et al., 1996; Berquin et al., 2007). In the past 100 years, the fatty acid composition of 
Western diets has undergone a dramatic change, largely due to a high increase in the 
consumption of omega-6 (ω-6) PUFA from vegetable oils and red meat, and less consumption of 
omega-3 (ω-3) PUFA (Weaver et al., 2009). This has resulted in an ω-6/ω-3 ratio of 25-40:1 in 
the US diets rather than near the ideal 1:1 ratio. Asian diets are lower in ω-6 and higher in ω-3 
than the Western diet due to more consumption of fish and other sea products and low 
consumption of plant oils and red meat. 
 Several studies have investigated the effects of ω-3 and ω-6 fat on prostate tumor cells. 
Omega-3 PUFA (eicosapentaenoic acid - EPA and docosahexaenoic acid - DHA) inhibit tumor 
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cell growth in animal models and human prostate cell lines (Rose and Connolly, 1991; Rose and 
Connolly, 1999), whereas ω-6 PUFA (linoleic acid - LA and arachidonic acid - AA) increase 
growth of human prostate tumor cell lines (Rose and Connolly, 1991; Connolly et al., 1997; 
Rose and Connolly, 1999). Epidemiologic studies also reported a decrease of metastatic prostate 
cancer risk and prostate cancer death in men who consume the most fish (Tzonou et al., 1999; 
Terry et al., 2001; Hedelin et al., 2007, Chavarro et al., 2008), a good source of EPA and DHA. 
Linoleic acid is the most abundant ω-6 PUFA in the human diet. It is abundant in many plant oils 
such as corn oil, safflower oil and sunflower oil. Linoleic acid is the precursor for the synthesis 
of AA, which is abundant in red meat and meat fat.   
Prostate cancer burden continues to increase because of the aging and growing population 
as well as nutritional patterns that tend to increase the risk for the disease. There is the need to 
identify and establish factors that might prevent or slow the progression of prostate cancer. If 
beneficial, a dietary change that includes the reduction in the intake of ω-6 fatty acids and 
increase the proportion of dietary ω-3 fatty acids may therefore be a powerful tool for prevention 
of mortality from prostate cancer.  
In this study, we tested the hypothesis that compared to a diet that approximates the ω-6 
fatty acid content of the Western diet, exposure to a diet with more ω-3 fatty acids during 
adulthood will slow the progression of prostate cancer, and to identify the underlying molecular 
factors. The C3(1)TAg mouse model was used for the study because it develops prostate cancer 
slowly  and has a well characterized disease progression making it suitable for prevention studies   
(Shibata et al., 1996).  We show that compared to a diet that is high in ω-6/ω-3 fat, consumption 
of low ω-6/ω-3 diet slows prostate carcinogenesis. 
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Materials and methods 
Mice 
Twenty female SV 129 mice, at 6wks of age, were obtained from Charles River Laboratories 
(Wilmington, MA), quarantined for 2wks, and transferred to a study room. Mice that bear a 
transgene for the SV40 large T antigen with a C3(1) rat prostatic steroid binding protein 
promoter were obtained from Dr. Jeffrey Green for breeding. The male transgenic mice develop 
prostatic intraepithelial neoplasia (PIN) that progresses to prostate carcinoma due to expression 
of the large T antigen in the prostate (Shibata et al., 1996). All mice were genotyped to confirm 
the presence of the transgene. 
 
Study design and feeding 
All female SV 129 mice were placed on a diet containing 10% w/w corn oil (high ω-6, control 
diet, ratio of ω-6/ω-3 was 50:1). After 2wks they were bred with homozygous C3(1) TAg 
transgenic male mice. All male hemizygous offspring were weaned to the corn oil diet and 
consumed this diet until the post puberty age of 7wks. Half of the offspring were retained on the 
corn oil diet to generate the high ω-6 CO-CO (mother - pup diet) group, while the remaining half 
were transferred to a higher ω-3 diet (test diet) to generate the CO-FS ( mother - pup diet) group.  
The high ω-3 diet contained 5% canola oil (to provide adequate essential ω-6 fatty acid) and 5% 
fish oil concentrate (ratio of ω-6/ω-3 in the diet was 1:3). The offspring were housed not more 
than 4 in a cage, numbered for individual identification and weighed weekly. All animals were 
maintained in an isolated environment in barrier cages and fed the specified diet. Mice were fed 
ad libitum with fresh food 6 days per week, and any leftover food in the cages was discarded. 
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 The animal protocol was approved by the Marshall University school of Medicine 
Institutional Animal Care and Use Committee.  
 
Diet 
Diets were prepared in the animal diet prep room of Marshall University School of Medicine, 
using an AIN-76-A rodent diet modified to contain 10% total fat (Table 4.1). The AIN-76-A diet 
is adequate for the supply of nutrition and growth of the mice (American Institute of Nutrition, 
1977). The control and test diets were isocaloric and isonutrient, and are relevant to human 
consumption. Casein, corn starch and other dry ingredients for the diets (except sugar) were 
obtained from MP Biomedicals (Solon, Ohio), omega-3 concentrates from fish oil (containing 
60% EPA + DHA) were obtained from Zone Labs Inc. (Danvers, MA) while sugar and oil 
(100% canola oil or 100% corn oil) were obtained locally. Diets were prepared in batches as 
needed and stored in sealed containers at -20oC to prevent bacterial growth and fat oxidation in 
the food. 
 
Assessment of transgene copy number 
Ear punches stored at -20oC were digested as previously described (Ion et al., 2010) and assessed 
for the presence of SV40 TAg transgene by real time PCR method, using an ABI Prism 7000 
instrument (Applied Biosystems, Foster City, CA).  
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Body weights 
To assess the effect of diet on body weight, mouse body weights were recorded weekly and 
terminally during dissection. 
 
Dissection and tissue collection  
Mice were euthanized at 24wks and 40 wks of age. A 24wks time point was chosen as adequate 
time for early stage disease progression in our heterozygote mice because previous studies 
indicated that C3(1)TAg male mice develop high-grade prostatic intraepithelial lesion (HGPIN) 
at 20wks (Shibata et al., 1996). PIN is the primary precursor of prostate cancer. The high-grade 
PIN in C3(1)Tag male mice progresses to prostate carcinoma by 28wks (Shibata et al., 1996). 
The 40wks time point therefore ensures advanced disease progression and provides for adequate 
time for intervention in our prevention study. After macroscopic evaluation during necropsy, the 
genitourinary (GU) bloc (consisting of the anterior prostate (AP), dorsolateral prostate (DL), 
ventral prostate (VP), seminal vesicle, bladder, proximal ductal deferens, and proximal urethra) 
was dissected and weighed to assess the effect of diet on GU weight. The AP, VP and DL 
prostate lobes were dissected from the GU apparatus with the aid of a dissecting microscope, and 
weighed to assess the effect of diet on prostate weight. GU blocs were fixed in phosphate-
buffered 10% paraformaldehyde for 4 hours and transferred to 70% ethanol until ready for 
histopathological analyses. Mouse inguinal fat, liver and prostate were collected and stored at -
80oC for other analyses.  
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Blood collection 
Blood (about 600 µl) was collected from each animal into EDTA vials by cardiac puncture at 
necropsy to assess testosterone and estrogen levels. Plasma was separated from blood samples by 
centrifugation and stored at -80 oC until assayed. 
 
Plasma measures 
Total testosterone and estrogen were measured in plasma obtained from individual mice from 
CO-CO and CO-FS groups at 24wks and 40wks, using the Testosterone EIA Kit or Estradiol 
EIA Kit respectively (Cayman Chemical Company, Ann Arbor, MI). Measurements were done 
in triplicate following the protocol provided in the kit.  
 
Histopathological assessment 
To assess cancer progression due to diet, GU apparatuses previously fixed in paraformaldehyde 
and thereafter in ethanol were sent to the Rodent Histopathology Core of Dana-Farber/Harvard 
Cancer Center for processing and pathology diagnosis. Briefly, the prostatic complex was 
paraffin embedded, sectioned on a slide (6 sections per prostate), and stained with hematoxylin 
and eosin (H&E). The animal identities were coded to avoid observer bias in the pathological 
diagnosis. Two independent evaluators analyzed all specimens. Observations were done for the 
presence and degree of epithelial hyperplasia and the presence of nuclear atypia in the epithelial 
cells in dorsolateral lobes of the prostate. Specimens with nuclear atypia were classified as 
LGPIN or HGPIN lesions following the guideline established by the Mouse Models of Human 
Cancer Consortium Prostate cancer Committee (Shappell et al., 2004). Scores from two 
evaluators were averaged. 
89 
 
Fatty acid composition analysis 
The fatty acid compositions of prostate, liver and fat at 24wks were analyzed by gas 
chromatography. Extraction of fatty acids was done as previously described (Ion et al., 2010). 
Fatty acids suspended in iso-octane were separated and identified using a PerkinElmer Clarus 
500 Gas Chromatography (Shelton, CT) with a Elite MWAX 30m x 0.53mm x 1.0µm 
crosslinked polyethylene glycol  Capillary Column, in the following conditions:  220oC for 100 
min, injector and flame ion detector at 240oC, helium carrier gas flow rate of 2.0ml/min. Peak 
identification was done using a customized standard (GLC #704) (Nu-Chek-Prep, Elysian, MN), 
which contains 10 fatty acids as methyl esters of stearate, oleate, linoleate, alpha linolenate, 
gamma linolenate, homogamma linolenate, arachidonate, eicosapentaenoate, docosapentaenoate, 
and docosahexaenoate. Fatty acid methyl esters were estimated as the percentage of the 
methylated fatty acids (area under the curve). 
 
Gene expression RT2 PCR assay 
Gene expression analyses of DL tissues from 24wks old mice on different diets (3 tissues per 
group) were carried out, using the Mouse Signal Transduction Pathway Finder™ RT2 profiler™ 
PCR Array (PAMM-014) (SuperArray Bioscience Corporation, Frederick, MD). This array was 
chosen to identify genes in signal transduction pathways that are influenced by high ω-3 fat diet 
and that may be applicable to cancer development. Briefly, DL prostates were dissected in RNA 
stabilization reagent (Omega Bio-tek, Inc., Norcross, GA) and frozen at -80oC until ready to use. 
Total RNA was isolated from frozen DL prostate tissue with RNeasy Fibrous Tissue Mini Kit 
(Qiagen, Valencia, CA), according to the manufacturer’s protocol. RNA yield, purity and 
integrity were determined using an Agilent 2100 Bioanalyzer (Santa Clara, CA). Further quality 
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control was performed on all RNA samples with the RT2 RNA QC PCR Arrays (SuperArray 
Bioscience Corporation, Frederick, MD). cDNA was prepared from RNA using RT2 First Strand 
Kit and amplified by real time PCR using SuperArray RT2 qPCR Master Mix on ABI Prism 700 
(Applied Biosystems, Foster City, CA), following the protocol provided by the manufacturer. 
Differential gene expression and statistical analysis of data were done using the SuperArray 
software. 
 
Immunoblot analysis 
Frozen DL prostate tissues (3 to 4 per group) were homogenized in Tri Reagent (Sigma-Aldrich, 
St. Louis, Mo), followed by protein extraction according to protocol from the manufacturer. 
Protein concentration was determined by BCA protein assay kit (EMD Biosciences, Inc. 
Darmstad Germany). Fifteen micrograms of protein were loaded onto a 4-20% Tris-HCL 
polyacrylamide gradient gel (Bio-Rad Laboratories, Hercules, CA), separated by electrophoresis 
and transferred onto a nitrocellulose membrane. Blots were blocked using 5% BSA in TBST for 
1 hour at room temperature and thereafter probed with primary antibodies in blocking buffer 
overnight at 4oC against: inhibitor of NFkappa-B kinase beta (IKKβ), B-cell leukemia/lymphoma 
2 (BCL2) (Cell Signaling Technology, Inc.); Nitric oxide synthase Type II (NOS2) (BD 
Biosciences), NFkappa-B(p65) (Santa Cruz Biotechnology, Inc.); or NF kappa-B inhibitor alpha 
(IKα) (Abcam Inc.) for 1 hour at room temperature. Beta-actin (Santa Cruz Biotechnology, Inc.) 
was used to normalize protein loading. Membranes were then incubated with either horseradish 
peroxidase (HRP) conjugated antimouse (Santa Cruz Biotechnology, Inc.) or antirabbit (PIERCE 
Inc.) secondary antibody as appropriate. A Chemiluminescence ECL Kit (PIERCE Inc.) was 
used for band detection. Densitometric analyses were carried out using ChemDoc XRS system 
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(Bio-Rad Laboratories, Hercules, CA) to acquire the image, followed by image analysis with 
“Quantity One” software, V.4.5.2 (Bio-Rad Laboratories, Hercules, CA).  
 
Immunohistochemistry  
Expressions of androgen receptor (AR) and proliferating cell nuclear antigen (PCNA) were 
assessed in mouse DL prostate by immunohistochemistry. Paraffin sections (6 prostate sections 
per slide) were deparaffinized in xylene, hydrated in a series of graded ethanol, and rinsed in 
distilled water. Antigen retrieval was done in a microwave oven using Vector Antigen 
Unmasking solution (Vector Laboratories, Inc., Burlingame, CA). This was followed by 
blocking endogenous peroxidase activity using 3% hydrogen peroxide and Avidin/Biotin activity 
using Vector Avidin/Biotin blocking kit (Vector Laboratories, Inc., Burlingame, CA) following 
the manufacturers protocols. After blocking, sections were treated with rabbit anti-AR 
(PG21)(Millipore, Temecula CA) or mouse anti-PCNA (Biogenex, San Ramon, CA) and 
thereafter with secondary antibodies and vectastain Elite ABC kit (Vector Laboratories, Inc., 
Burlingame, CA) for rabbit antibody or Vector M.O.M kit (Vector Laboratories, Inc., 
Burlingame, CA) for mouse primary antibodies. Sections were incubated with 3, 3’-
diaminobenzidine (Vector Laboratories, Inc., Burlingame, CA) and counterstained using 
hematoxylin. The levels of proliferation or AR expression were compared between the two diet 
groups by counting the number of cells with PCNA or AR positively stained nucleus respectively 
per 1000 cells within viable areas of lesions. Apoptosis was assayed by morphological 
identification (nuclear and cellular condensation, fragmentation of nuclei, and/or membrane 
blebbing and fragmentation of the cell into apoptotic bodies) of apoptotic cells (Narayanan et al, 
92 
 
2004). The numbers of cells undergoing apoptosis based on morphological indicators in 1000 
epithelial cells of viable areas of lesions were counted to estimate an apoptotic index.   
 
Statistics 
Western blot protein expression levels, apoptosis, AR and PCNA levels, fatty acid composition, 
mean body weight gain, prostate and GU weight between diet groups and across time, were 
statistically analyzed by t-test. Testosterone and estradiol levels between diet groups and across 
time were analyzed by Mann Whitney test. The differences in prostate lesion incidence between 
diet groups were assessed by Fisher exact test. All statistical tests were performed using Prism 
software.  
 
Results 
Effect of diets on tissue lipid composition  
The lipid compositions of the prostate, liver and fat at 24wks of age were analyzed. Mice at this 
age were on either corn oil diet or fish oil diet. As expected, the lipid composition of tissues 
reflected the lipid content of the diet (Supplementary figure 4.6). The prostate, liver and fat of 
mice on corn oil diet contained significantly more (t-test at p < 0.05) LA than the prostate, liver 
and fat of mice on fish oil diet. AA was significantly higher (t-test at p < 0.05) in the liver and 
prostate but not in the fat of mice on the corn oil diet than mice on fish oil diet. The liver, 
prostate and fat of mice on the fish oil diet contained significantly more (t-test at p < 0.05) ALA, 
EPA and DHA than the liver, fat and prostate of mice on corn oil diet.  
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Effect of diets on body weight gain  
To assess the effect of diet on body weight of mice, we weighed the mice weekly from the time 
of weaning to time of sacrifice (40wks). Control and test diets were designed to be nutritionally 
balanced and with the same percentage of energy from fat. There was no significant difference in 
body weight gain between mice on the high ω-6 control diet (CO-CO group) and mice on the 
high ω-3 test diet (CO-FS group) (Figure 4.1A). 
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Fig. 4.1 Effect of diets on average body weight gain, prostate weight and GU weight   
between CO-CO and CO-FS mice. A) Average body weight gain. Data are from measurements 
of body weight gain for individual mice from the time of weaning to 40wks of age. Analysis by 
t-test showed no significant difference in body weight gain between the two groups at p< 0.05. n 
= 9 / group. B) Prostate weight at 24wks and 40wks of age. Mouse DL, AP, and VP lobes were 
dissected and weighed, and the sums were expressed as milligrams per 25 grams body weight. 
The average weight was significantly different between the two groups at 24wks (n = 15 – 19 / 
group) and 40wks (n = 12 / group) by t-test and at p< 0.05. Average prostate weight significantly 
increased in both groups with time by t-test at p< 0.05. C & D) Gross appearance of some GU 
and GU weight at 24wks and 40wks of age respectively. Mouse GU were dissected at euthanasia 
and weighed. The weights were expressed as milligrams per 25 grams body weight. The average 
GU weight was not significantly different between the two groups at 24wks but significantly 
lower at 40wks in the CO-FS group than in the CO-CO group by t-test and at p < 0.05, (n = 19 / 
group). Average GU weight increased significantly in CO-CO group with time.* Significantly 
different between groups, † significantly different across time at p< 0.05. 
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Effect of diets on prostate weight and GU weight  
We assessed the effect of diet on prostate and GU weights as an indicator of progression of 
prostate tumorigenesis. Two time points, 24wks and 40wks, were selected for assessment of 
disease progression. The prostate of mice on the high ω-3 diet weighed significantly less than 
prostate of mice on the high ω-6 diet at 24wks and 40wks (by t-test at p < 0.05) (Figure 4.1B). 
Mice on high ω-3 diet had an increase of 10.21mg in prostate weight between 24wks and 40wks, 
while mice on high ω-6 diet had an increase of 22.49mg. Diet did not affect the GU weight 
significantly at 24wks (Figure 4.1C & D). The gross appearance of the GU bloc (Figure 4.1C) 
was similar between the two diet groups at 24wks. In contrast, the gross appearance of the GU 
bloc of mice on high ω-3 diet appeared smaller and the average weight was significantly lower 
than GU bloc of mice on high ω-6 diet at 40wks (Figure 4.1D).  
 
Effect of diets on prostate histopathology  
The histology of the prostate in C3(1) TAg mice of various ages has previously been 
documented, and it is known that on a usual diet, mice develop HGPIN in the prostate beginning 
about 20wks of age, which subsequently progresses to adenocarcinoma with advancing age 
(Shibata et al., 1996) . Dorsolateral prostates of C3(1) TAg mice were evaluated in CO-CO  and 
CO-FS groups at 24wks and 40wks of age. The degree and progression of epithelial hyperplasia 
and atypia were compared between the two diet groups (Figure 4.2). There was a slower 
progression of disease in mice on the high ω-3 diet than in mice on the high ω-6 diet at each time 
point (Figure 4.2). At 24wks, there was a significantly low proportion of LGPIN incidence (45% 
in CO-CO vs 64% in CO-FS) and significantly high proportion of HGPIN incidence (55% in  
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CO-CO vs 36% in CO-FS) in CO-CO group compared to CO-FS group (by Fischer exact test at  
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Fig. 4.2 Effect of diets on the incidence of PIN and adenocarcinoma lesions in the DL 
prostate. A-D) Representative H & E stained sections from 24wks and 40wks old mice. A & C) 
illustrate the presence of LG- and HG-grade PIN and ADC lesions as demonstrated by epithelial 
cells proliferation, hyperchromasia, nuclear enlargement and membrane irregularity. B & D) 
Consumption of high ω-3 diet resulted in marked reduction of epithelial cells proliferation, 
hyperchromasia, nuclear enlargement and membrane irregularity. E ) incidence of PIN lesions 
and adenocarcinoma in CO-CO and CO-FS groups at 24wks and 40wks of age. Prostate 
specimens were histologically examined for lesions by two independent evaluators and scores 
were averaged (n=11 – 12 / group). Pictures were taken at X40 magnification. (Star indicates 
LGPIN, low-grade prostatic intraepithelial neoplasia; arrow indicates HGPIN, high-grade 
prostatic intraepithelial neoplasia; arrow head indicates ADC, adenocarcinoma. *, †, ‡ represent 
significant difference in LGPIN, HGPIN and ADC respectively between CO-CO and CO-FS 
group at p< 0.05).  
 
p < 0.05).  No adenocarcinomas (ADC) were observed in mice at 24wks. There was a 
significantly lower proportion of LGPIN incidence and higher proportion of ADC incidence in 
CO-CO group compared to CO-FS group at 40wks (by Fischer exact test at p < 0.05). At 40wks, 
the CO-CO group had 18% LGPIN, 46% HGPIN and 36% ADC while the CO-FS group had 
36% LGPIN, 46% HGPIN and 18% ADC.  
 
Effect of diets on plasma estrogen and testosterone levels and expression of AR  
 Plasma testosterone and estradiol levels were measured by enzyme immunoassays. Testosterone 
levels were not significantly higher in mice on the high ω-6 diet than in mice on the high ω-3 
diet, or as mice progressed in age in mice on the high ω-6 diet (Figure 4.3A). To further test the 
effect of diet on testosterone action, androgen receptor expression in the dorsolateral prostate 
was analyzed by immunohistochemistry. The expression level of AR in dorsolateral prostate was 
significantly higher in mice on the high ω-6 diet than in mice on the high ω-3 diet at 40wks but 
not at 24wks of age (Figure 4.3B). There were significant differences in the levels of estradiol in 
mice  
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exposed to high ω-6 diet compared to mice on high ω-3 diet at 24wks and 40wks of age (Figure 
4.3C). Estradiol level was significantly increased in mice that consumed high ω-3 diet compared 
to mice that consumed high ω-6 diet at 24wks. However at 40wks, estradiol level was 
significantly less in mice that consumed high ω-3 diet (10.45pg/ml) compared to mice that 
consumed high ω-6 diet (15.89pg/ml). Consumption of high ω-3 diet resulted in a significant 
decrease in estradiol level as mice progressed in age while consumption of high ω-6 diet resulted 
in no significant change in estradiol level as mice progressed in age. 
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Fig. 4.3 Effect of diets on plasma testosterone and estradiol levels. Mice on both diets were 
sacrificed at 24wks and 40kws of age. Plasma was obtained for individual assay from blood 
collected from mice. A) The level of testosterone was less  in mice from CO-FS group than mice 
from CO-CO group at 24wks and 40wks (n= 12 – 19 / group), and increased  as mice progressed 
in age in the CO-CO group. These differences were not significant by Mann Whitney test at p< 
0.05. B) Expression of AR was lower significantly in the CO-FS group than the CO-CO group at 
40wks by t- test, n = 5 / group. A total of 1000 epithelial cells within viable areas of lesions per 
slide were counted for AR expression assay. C) Estradiol levels were significantly different 
between the two groups at 24wks and 40wks by Mann Whitney test at p< 0.05 (n= 15 – 20 / 
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group). Estradiol level was higher but not significantly as mice progressed in age in CO-CO 
group, and decreased significantly in CO-FS group than CO-CO group at 40wks and as mice 
progressed in age in CO-FS group. * Significantly different at p< 0.05, † significantly different 
across time at p< 0.05.  
 
Effect of diets on gene and protein expression in the DL prostate at 24wks of age  
To investigate the molecular mechanism by which high ω-3 diet may be slowing down the 
progression of prostate tumorigenesis in the DL prostate, we analyzed the expression of several 
genes involved in signal transduction pathways. We chose the 24wks time point because mice 
are in the early stages of prostate carcinogenesis, and, therefore, gene expression difference due 
to the diet and not to the tumor can be assessed. A total of 84 genes were quantitatively assayed 
using the Mouse Signal Transduction Pathway Finder™ RT2 profiler™ PCR Array. Table 4.2 
presents 31 genes with more than 2 fold differences (using SuperArray statistical analyses 
software) between CO-FS and CO-CO group at 24wks of age. We further analyzed the genes 
using the Ingenuity Systems software (IPA 8.0), and this showed that a number of the altered 
genes are associated with NFκB and apoptosis pathways (data not shown). We chose NFκB 
inhibitor alpha (IKα), IkB kinase beta (IKKβ), NFκBp65 and nitric oxide synthase 2 (NOS2) 
from the NFκB pathway, and B-cell leukemia/lymphoma 2 (BCL2) from the apoptosis pathway 
for Western blot analysis. Western blot results showed Ikα protein (Figure 4.4A) to be increased 
but not significantly and BCL2 protein (Figure 4.4B) to be significantly decreased due to 
consumption of high ω-3 diet. NFκBp65, IKKβ and NOS2 proteins were also significantly 
decreased due to consumption of high ω-3 diet (Figure 4.4A).  
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Table 4.2 Gene expression in dorsolateral prostate at 24wks of age 
 
Mice were placed on either corn oil diet or transferred to fish oil diet at 7wks of age. Gene expression in 
the DL prostate of mice at 24wks of age was performed by real time reverse transcriptase PCR. Genes 
with more than 2-fold differences in mRNA expression are shown. Results are from three different 
samples for each group.  
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Fig. 4.4 Effect of diets on proteins in NFkB and apoptosis pathways in DL prostate. A) 
Protein expression of NFκBp65, IKα, IKKβ and NOS2 in the DL prostate and their 
corresponding densitometric analyses in 24wks old mice. Expression of IKα protein was 
increased but not significantly, while the expressions of NFκBp65, IKKβ and NOS2 proteins 
were significantly decreased in DL prostate of mice on high ω-3 fat diet than mice on high ω-6 
fat diet. B) Protein expression of BCL2 in the DL prostate and the densitometric analysis in 
24wks old mice. Expression of BCL2 protein was decreased significantly in the DL prostate of 
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mice on high ω-3 fat diet compared to mice on high ω-6 fat diet. Equal loading of protein in the 
lanes was confirmed by β-actin. Values are relative density corrected for β-actin. * Significantly 
different at p< 0.05, n = 3 – 5 / group. 
 
Effect of diets on cell proliferation and apoptosis in the dorsolateral prostates  
 We further tested the molecular mechanism by which diet may be influencing the progression of 
prostate tumorigenesis by comparing the proliferation and apoptosis in the areas of lesions in DL 
prostate of mice from the two different diet groups. Proliferation was significantly decreased 
(Figure 4.5A) and apoptosis was significantly increased (Figure 4.5B) in prostate epithelial cells 
in mice that consumed high ω-3 diet compared to mice that consumed high ω-6 diet.   
 
 
 
 
 
 
 
 
104 
 
 
105 
 
Fig. 4.5 Effect of diets on the extent of proliferation and apoptosis in DL prostate. DL 
prostate sections from the two groups were assessed for proliferation by immunohistochemistry 
analysis of PCNA at 24wks and 40wks (Fig 4A,B,C,D). Proliferation was significantly decreased 
in mice on high ω-3 diet compared to mice on high ω-6 diet by t-test at p< 0.05 (Fig 4E). 
Apoptosis was assessed by morphological identification of apoptotic cells in H & E stained 
sections (Fig 4F,G,H,I), and was significantly increased in mice on high ω-3 diet compared to 
mice on high ω-6 diet by t-test at p< 0.05 (Fig 4J). A total of 1000 epithelial cells within viable 
areas of lesions per slide were counted for proliferation and apoptosis assays.  n = 5 mice / group 
for proliferation assay, n = 7 mice / group for apoptosis assay. Pictures were taken at 40X 
magnification. Arrow indicates apoptotic cells.     
 
Discussion 
One obvious characteristic of the Western diet is the high intake of ω-6 fat which has been 
associated with high prostate cancer risk in epidemiologic studies (Lanier et al., 1980; 
Giovannucci et al., 1993; Augustsson et al., 2003). These studies also suggest that consumption 
of fish or fish oil, which are very high in ω-3 fatty acids, may reduce prostate cancer risk (Terry 
et al., 2001; Augustsson et al., 2003). We investigated the effect of high ω-3 and low ω-6 diet in 
the development of prostate cancer and the molecular mechanism that might be involved. The 
24wks and 40wks intervention time points were chosen as adequate time for early stage disease 
progression and advanced disease progression since studies indicate that C3(1)TAg male mice on 
a usual diet, develop HGPIN beginning about  20wks and progressing to prostate carcinoma 
from 28 wks (Shibata et al., 1996; Maroulakou et al., 1994). We chose the C3(1) TAg model for 
this study for its well characterized disease progression from normal to PIN to adenocarcinoma 
(Shibata et al., 1996). 
A switch from high ω-6 diet to a high ω-3 diet at post-puberty was chosen for this study 
to model a change in diet initiated in adulthood. Post-pubertal consumption of a high ω-3 fat diet 
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significantly slowed the progression of prostate tumorigenesis in mice as observed by the 
reduced number of high grade prostate lesions in mice on high ω-3 diet compared to mice on 
high ω-6 diet. The ability of high the ω-3 diet to slow promotion of tumorigenesis in our mouse 
model was also observed as decreased GU bloc and prostate weights in mice that consumed high 
ω-3 diet. At the molecular level, mice on high ω-3 diet showed increased apoptosis and 
decreased proliferation in epithelial cells of the prostate as shown by decreased expression of the 
antiapoptotic gene BCL2 at mRNA and protein levels, and less staining for PCNA compared to 
mice on the high ω-6 diet. The EPA and DHA in the high ω-3 diet were accumulated in the 
prostate of mice fed with the high ω-3 diet, which likely slowed of disease progression. This is 
supported by Rose and Connolly, 1991, indicating that EPA and DHA suppress proliferation and 
promote apoptosis in prostate cancer cells. 
 To identify the underlying molecular factors by which the high ω-3 diet may be slowing 
down the progression of prostate tumorigenesis, we analyzed for the expression of some genes 
involved in NFκB pathway because further analysis of the gene array into pathway-focused array 
(IPA 8.0) showed the NFkB pathway to be differentially activated. NFκB is a key mediator of 
survival, and is upregulated during prostate cancer progression (Suh and Rabson., 2004; Huang 
et al., 2001). While in an inactive state, NFκB is located in the cytosol complexed with the 
inhibitor of NFκB (IK). A variety of extracellular signals can activate the inhibitor of NFκB 
kinase (IKK) which in turn, phosphorylates the IK protein resulting in the dissociation of IK 
from NFκB, and its eventual degradation. The activated NFκB is then translocated into the 
nucleus to regulate the expression of downstream genes.  Consumption of high ω-3 fat diet did 
not increase the expression of IK significantly however, it did significantly decrease the 
expression of IKK protein (Figure 4A). The mRNA expression fold for IK and IKK was 1.2 and 
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-1.97 (CO-FS vs CO-CO) respectively. Consumption of high ω-3 fat diet also significantly 
decreased the expression of NFκBp65 subunit and NOS2, a downstream gene in the NFκB 
pathway. NOS2 is highly expressed in prostate tumors (Uotila et al., 2001).  
We also investigated the effect that high ω-3 diet may have on testosterone and estradiol 
levels in circulation. Testosterone has been vigorously studied because of its role in promoting 
prostate cancer, but the role of estrogen in prostate disease has received very little attention, 
despite reports that estrogen may promote prostate tumorigenesis (DeKlerk et al., 1979; 
Henderson et al., 1988; Thomas and Keenan, 1994; Ho, 2004). Serum testosterone level declines 
in the aging male whereas estrogen level increases and remains constant (Vermuelen et al., 2002; 
Kaufman and Vermeulen, 2005). However, rising estradiol level may increase prostate 
sensitivity to testosterone via upregulation of AR (Moore et al., 1979; Trachtenberg et al., 1980). 
We showed that consumption of high ω-3 diet resulted in significantly lower estradiol level and 
lower testosterone level, with a concomitant significant decrease in the expression level of 
androgen receptor, suggesting a decrease in androgen stimulation due to consumption of high ω-
3 diet. 
We conclude that a high ω-3 diet slowed prostate tumorigenesis in the C3(1) Tag mouse 
model, and the mechanisms involved may include lowering of testosterone and estradiol levels, 
resulting in lower expression of androgen receptor, which in turn leads to a decrease in the 
expression levels of genes in the NFκB and the antiapoptotic BCL2 pathways. These molecular 
changes could account for the suppressed proliferation and enhanced apoptosis that we observed 
within the lesions in the dorsolateral prostates of the mice. Therefore, a dietary change by 
humans that involves consumption of more ω-3 fat such as obtained from fish and fish oil, 
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instead of corn oil with little or no ω-3 fat, may be helpful in the suppression and prevention of 
prostate cancer.  
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Supplementary Materials 
                   Table 4.1. Diet Composition 
 
The AIN-76A mouse recipe was modified to contain 10% w/w corn oil (high ω-6, low ω-3 control diet) 
with an ω-6/ω-3 ratio of 50 or 5% canola oil and 5% fish oil concentrate (low ω-6, high ω-3 test diet) with 
an ω-6/ω-3 ratio of 0.3. Both diets were isocaloric and isonutrients and are adequate for growth and 
nutrition of mice. 
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Fig. 4.6. Effect of diets on major ω-3 and ω-6 fatty acid levels in mice tissues. The results of 
t-tests showed significant differences in fatty acid levels in mouse tissues due to diet. ω-6 fatty 
acids – LA (Linoleic acid), AA (Arachidonic acid). ω-3 fatty acids – ALA (α-Linolenic acid), 
EPA (Eicosapentaenoic), DHA (Docosahexaenoic acid). * Significantly different at p< 0.05, n = 
5 to 6 mice / diet group. 
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CHAPTER FIVE 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
The patterns of human food production and consumption have changed greatly due to 
industrialization and urbanization, contributing to increasing rates of diseases including cancer 
(Simopoulos, 2008).  Such changes include an increase in omega-6 fatty acids and a decrease in 
omega-3 fatty acids in the Western diet (Simopoulos, 2002). This is in contrast to an omega-
6/omega-3 ratio of about 1:1 found in wild animals and on which humans evolved (Simopoulos 
et al., 1999; Simopoulos, 2008). The balance of omega-6 and omega-3 fatty acids is important 
and required for homeostasis and normal development (Simopoulos, 2006). Although cancer is a 
disease of mutated genes and can be inherited, environmental factors such as diet play important 
roles in influencing the disease (Doll and Peto, 1981). Migration studies show that cancer risk of 
adults who migrate to the USA from regions with low rates of cancer incidence such as Asia, 
increases to that of the new country (Cook et al., 1999). Asian diets are lower in omega-6 and 
higher in omega-3 than the Western diets. These reports thus imply that cancer may be delayed 
or prevented by increasing the dietary omega-3/omega-6 ratio.  
Although epidemiology and experimental studies have been carried out on the benefits of 
consuming high omega-3 fat and lowering the intake of omega-6 fat (in contrast to high omega-6 
and very low omega-3 in the Western diet) in reducing the risk for some diseases, reports are 
inconsistent for cancer. There is also a growing interest in the use of natural products to suppress 
cancer growth (Bennett et al., 2009) and to prevent it. Thus, there is need for more knowledge 
about dietary components with potential benefits in suppressing cancer growth. To address this 
problem, we fed the C3(1) TAg transgenic mice with diet modified to contain more  
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omega-3 and less omega-6 fatty acids than the levels in Western diet, using (1) canola oil, (2) 
walnut or, (3) fish oil concentrate.  Our dietary modifications (canola oil, walnut and fish oil 
diets) did not significantly affect body weight compared to the control diet (corn oil diet). The 
benefits of such diets against breast and prostate cancers were investigated.  The C3(1) TAg mice 
bear a transgene for the SV40 large T antigen with a rat prostatic steroid binding protein 
promoter, which drives the expression of the transgene in the epithelium of the mammary and 
prostate glands thereby inducing transformation and tumorigenesis (Yoshidome et al., 1998). We 
chose C3(1) TAg mice for the studies because they develop mammary and prostate tumors that 
are histologically similar to human breast and prostate cancers (Green et al., 2000).  
 In our first study we placed female mother mice on a diet containing 10% w/w corn oil 
(control diet) or 10% w/w canola oil (test diet), and during gestation and lactation of the 
offspring. All female offspring from these mother mice were weaned to corn oil diet and 
identified as corn / corn (CO/CO) or canola / corn (CA/CO) groups. In utero and lactation 
exposure to the canola oil diet caused a significant delay in mammary gland tumor formation in 
the offspring. As mice advanced in age, almost as many tumors, but significantly less tumor 
burden, developed in the CA/CO mice compared to the CO/CO mice. Differences in the 
expression of genes involved in proliferation, differentiation and apoptosis were observed in the 
mammary gland of adult mice, supporting the notion that in utero diet exposure may be 
influencing gene imprinting. There was a higher expression of CEBPβ (a transcription factor 
involved in the transcription of multiple factors involved in proliferation, differentiation and 
apoptosis in the mammary gland, (Grimm and Rosen, 2003)), and lower expression of fatty acid 
synthase at mRNA and protein levels in CA/CO group than in CO/CO group. Fatty acid synthase 
is associated with human mammary carcinogenesis (Esslimani-Sahla et al., 2007).  The 
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expression of Egr1, a tumor suppressor, was increased in CA/CO group. The inhibitor of κB 
kinase β (IKKβ) and genes downstream in the NFκB pathway, namely inducible nitric oxide 
synthase (iNOS), tumor necrosis factor (TNF) and vascular cell adhesion molecule 1 (Vcam1), 
were less expressed in CA/CO mice, suggesting the inactivation of the NFκB pathway by the 
canola oil diet. Genes in the apoptotic pathway were also differentially expressed in the 
mammary gland of adult mice. The pro-apoptotic gene, Bcl-2 associated X (BAX), was more 
expressed and the anti-apoptotic gene, BCL-2-like-1(Bcl2l1) was less expressed in the CA/CO 
group.  
In our second study, we investigated the regular consumption of walnut and its influence 
on breast cancer risk. The regular consumption of walnut in a population means that offspring in 
such a population are exposed to the nutrients from walnut during gestation, lactation and at 
adulthood. Thus, in our investigation, we considered four experimental groups namely; corn 
oil/corn oil (CO/CO), corn oil/walnut (CO/walnut), walnut/walnut, or walnut/corn oil 
(walnut/CO); where the first diet was the maternal diet and the second diet was the offspring’s 
diet.  
 Consumption of walnut by mother and offspring (walnut/walnut) as expected in a 
population that consumes walnut regularly, significantly reduced tumor size, tumor multiplicity 
and tumor incidence in mice mammary glands compared to in the mammary glands of mice not 
exposed to walnut (CO/CO). Similarly, consumption of walnut after weaning (CO/walnut) as 
would occur when children move to a different environment or choose to make walnut part of the 
diet, reduced tumor size, tumor incidence and significantly reduced tumor multiplicity in mice 
mammary glands compared to in the mammary glands of mice not exposed to walnut, but not as  
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much as was observed in the mammary glands of the walnut/walnut group. Offspring who were 
exposed to walnut via gestation and lactation alone (walnut/CO) showed less reduced tumor 
mass and multiplicity compared to the CO/walnut group, while tumor incidence was similar to 
the control group. Exposure to dietary walnut altered several genes associated with mitogenesis, 
NFκβ among others. Western blot analyses of genes in the NFκβ pathway showed that walnut 
consumption resulted in increased expression of NFκβ inhibitor alpha (Nfκbia) while a longer 
exposure to walnut (walnut/walnut) also resulted in decreased expression of inhibitor of NFκβ 
kinase (IKK). These results suggest that walnut consumption may be suppressing mammary 
gland tumorigenesis. A comparison between the walnut diet and the canola diet with the same 
amount of α-linolenic acid showed that, walnut consumption (Walnut/Walnut) provided 
additional significant suppression of tumor development, compared to the canola oil diet. 
  In our third study, fish oil concentrate was used along with canola oil to obtain a high 
omega-3- low omega-6 diet that included EPA and DHA (test diet), and investigated the effects 
of such a diet on the risk for prostate cancer and the molecular mechanism that might be 
involved. EPA and DHA are abundant in fish oil (Petrik et al., 2000) while canola oil contains 
high amounts of LA and ALA. Hemizygous male pups from mothers on control corn oil diet 
(high omega-6/omega-3) were weaned on corn oil diet until a post puberty time point. This 
model equates to adulthood in the human and a time at which diet choices can be made. Half of 
the offspring were transferred to the high omega-3 fish oil diet while the remaining half were 
retained on the corn oil diet. Two experimental groups were therefore considered for this study 
namely; corn oil/corn oil (CO/CO) and corn oil/fish oil (CO/FS); where the first diet was the 
maternal/weaning diet and the second diet was the offspring’s diet. Twenty four weeks and forty 
weeks were considered for tumor progression because on a usual diet, C3(1) TAg male mice 
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develop HGPIN beginning about 20wks and progressing to prostate carcinoma from 28wks 
(Maroulakou et al., 1994; Shibata et al., 1996). 
Post pubertal consumption of high omega-3 fat diet resulted in decreased GU and 
prostate weights, and slower development of high grade prostate lesions, with a concomitant 
increase in apoptosis and decrease in proliferation in the epithelial cells of the prostate of mice. 
Pathway-focused array (IPA 8.0) analysis of the gene array results showed genes in the NFκβ 
pathway to be differentially expressed due to diet. Consumption of high omega-3 fat diet 
increased the expression of inhibitor of NFκB (IK) and significantly decreased the expression of 
inhibitor of NFκB kinase (IKK). Consumption of high omega-3 fat diet also significantly 
decreased the expression of NFκBp65 subunit and NOS2. High omega-3 diet consumption 
resulted in significantly lower estradiol level and lower testosterone level with a concomitant 
significant decrease in the expression level of androgen receptor, suggesting a decrease in 
androgen stimulation due to consumption of high omega-3 diet.  
Our findings have shown that reducing the omega-6/omega-3 ratio in the diet can have a 
suppressive effect on mammary and prostate tumorigenesis in the transgenic mice. The 
additional significant suppression of tumorigenesis in the mammary gland via consumption of 
walnut diet compared to canola oil diet suggests that omega-3 fatty acids may interact with some 
other dietary components for greater effects. This is not surprising because studies have also 
shown that the anticarcinogenic and antitumorigenic benefits of garlic likely arise from a wide 
variety of components, possibly working synergistically (Krest et al., 2000; Amagase et al., 
2001; Don et al., 2001; Lind, 2004). A study by Krishnan et al., (2007) showed that combination 
of calcitriol
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and genistein was more effective in retarding prostate cancer cell growth than either agent alone. 
Testing every possible combination and fraction before recommendation is obviously a daunting 
task. Therefore, consumption of diets that contain a variety and balance of food may be more 
beneficial in the prevention of cancer because multiple food substances that may work both 
synergistically and independently are supplied to the body.  
 The suppression of mammary gland tumorigenesis in the offspring of mothers that 
consumed canola oil could be a pointer to an epigenetic modification due to mother’s diet. 
Interestingly in utero exposure to the walnut diet did not suppress mammary gland tumorigenesis 
in the offspring. In addition to some other genes, the tumor suppressor gene Early growth 
response 1, was more expressed in mammary gland of offspring of mothers consuming canola oil 
diet or walnut diet. However, the expression of Fatty acid synthase (Fas) was suppressed in the 
mammary gland of offspring of mothers consuming canola oil diet, and increased in the 
mammary gland of offspring of mothers consuming walnut diet. Expression of Fatty acid 
synthase is associated with the early stages of mammary tumorigenesis, and its inhibition is 
associated with apoptosis in breast cancer cells (Esslimani-Sahla et al., 2007; Bandyopadhyay et 
al., 2006). One mechanism by which the consumption of canola oil diet by mothers suppressed 
mammary gland tumorigenesis in the offspring may be via the epigenetic modification resulting 
in the suppression of expression of Fas and some other genes. The hypothesis that “maternal 
consumption of diet high in omega-3 fatty acid during gestation and lactation will suppress 
mammary gland tumorigenesis in the offspring via the inhibition of histone deacetylase (HDAC) 
activity” may test this notion. Some dietary components from gallic and cruciferous vegetables 
are reported to inhibit the activity of HDAC, inhibiting cell proliferation and stimulating 
apoptosis in cancer cells (Ross, 2007). Also, because in utero exposure to the walnut diet did not 
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suppress mammary gland tumorigenesis in the offspring as observed in offspring of mothers that 
consumed canola oil diet, it is suggestive that variations in response to different diets may occur 
due to differences in the diet, the timing, duration or the genetics of the individual. 
Furthermore, the gene-diet interactions observed when corn oil was substituted with 
canola oil, walnut or fish oil concentrate were interesting. Several of the genes differentially 
expressed at mRNA and/or at protein levels due to diet in our studies, are involved in 
proliferation, apoptosis and differentiation. Our studies showed that NFκB and apoptosis 
pathways may be targets of our diet interventions to suppress tumorigenesis in mammary gland 
as well as in the prostate of the mice. NFκB is a key mediator of survival, and is upregulated 
during breast and prostate cancer progressions (Huang et al., 2001; Helbig et al., 2003; Suh and 
Rabson, 2004).  NFκB is activated in inflammatory process, and its activation inhibits apoptosis 
and increase proliferation in cancer cells (Escárcega et al., 2007). The inflammatory genes 
Interleukin 1 alpha and Interleukin 2 receptor alpha, were less expressed due to consumption of 
diet high in omega-3 and low in omega-6 fatty acids in our studies. Interestingly, the expressions 
of these genes as well as androgen receptor (AR was less expressed in the DL prostate due to 
consumption of high omega-3 diet) are modulated by NFκB (Ballard et al; 1988; Mori and 
Prager, 1996; Zhang et al; 2004). However, while Early growth factor 1 gene, a target gene of 
NFkB (Zhou et al., 2003), was more expressed in the mammary gland, its expression was 
suppressed in the dorsolateral prostate of the mice consuming diet high in omega-3 and low in 
omega-6 fatty acids, suggesting that different genes may be targets of NFkB in different organs. 
Other studies have shown that diet components can slow proliferation and induce apoptosis in 
tumors (Martin, 2007; Meeran and Katiyar, 2008). More work will be needed to elucidate the 
underlying molecular mechanisms of the effect of our high omega-3 diets in suppressing 
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mammary gland and prostate tumorigenesis.  The differential gene expression levels observed in 
the mammary gland of offspring due to the mother’s diet suggest epigenetic effects of the diet.  
Food components such as selenium, retinoic acid and sulforaphane influence DNA methylation 
patterns (Ross, 2003; Dashwood and Ho, 2007). A dietary change from high omega-6/omega-3 
diet to a low omega-6/omega-3 by expectant mothers may be helpful in decreasing the risk for 
breast cancer in their offspring by suppressing mammary tumor incidence in the offspring. 
The future directions of these studies will be to determine if consumption of canola oil 
diet and our control corn oil diet by normal mice will amount to similar morphological and gene 
expression changes seen in the transgenic mice. Such a study may yield biomarkers of reduced 
risk of mammary gland cancer that may be useful in clinical trials. Analysis of our results from 
the walnut study suggested that vitamin E, an antioxidant, in the walnut may be contributing to 
the additional benefit against mammary gland tumorigenesis observed in our mouse model.  A 
further study that provides a combination of omega-3 fatty acid and vitamin E in diet versus diet 
with omega-3 or vitamin E alone would shed more light on this notion.  
The in utero exposure to high omega-3 diet compared to high omega-6 diet, and the 
effect on life time risk of prostate cancer in offspring should be investigated. This is desirable 
because our female study showed that mother’s diet may be imprinting genes in the offspring to 
affect later cancer development in the mammary gland. A clinical study of placing normal male 
individuals on omega-3 supplement to check on prostate cancer biomarkers as influenced by 
omega-3 fatty acid consumption should also be investigated. 
In summary, substituting corn oil with canola oil in the maternal diet reduced the risk for 
mammary gland tumorigenesis in the offspring, and the consumption of walnut also reduced the 
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risk for mammary gland tumorigenesis compared to consumption of corn oil diet in transgenic 
mice. Substituting corn oil with fish oil reduced the risk for prostate tumorigenesis in  
transgenic mice.  Thus, a dietary change that involves consumption of diets with higher omega-3 
and lower omega-6 fatty acids than currently obtained in the Western diets could be beneficial in 
decreasing the risk for breast and prostate cancers.  
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